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  Bartonella quintana, a Gram-negative bacterial pathogen, causes Trench fever, bacillary 
angiomatosis and endocarditis.  Transmitted by the human body louse (Pediculus 
humanus corporis), the agent has a tropism for erythrocytes in humans.  In vitro growth 
requires an extraordinary concentration of hemin, and genomic analyses indicate several 
potential uptake systems and iron-responsive regulators.  Transcription of the hbp genes 
(hemin binding protein genes) is responsive to alterations in available hemin and an 
HbpA homolog in B. henselae reportedly functions as a hemin receptor in E. coli hemA 
strain EB53.  B. quintana hbpA was not able to complement EB53, indicating that it is 
not a hemin receptor.  A functional hemin receptor and coordinate uptake system is 
encoded by the hemin utilization (hut) locus.  B. quintana hutA was able to complement a 
hemA mutation in E. coli EB53 and was shown to be TonB-dependent using an isogenic 
E. coli hemA tonB strain.   
  Fur (ferric uptake regulator) has been described as a global iron-responsive regulator in 
γ-proteobacteria.  If expression is forced, B. quintana fur is able to complement an E. coli 
fur mutant, but an endogenous promoter for the gene could not be located and native 
expression in B. quintana was not detected.  Overexpression of the iron response 
regulator (Irr), a Fur family member, in B. quintana repressed hut locus transcription.  
Previous studies showed that Irr interacted with a consensus motif, the H-box, in the 
promoter of the hbp genes.  A region with homology to the H-box consensus is present in 
the divergent promoter between hutA and tonB and in the promoter region of hemS. 
  The fate of hemin in the bacterial cytoplasm is not well understood.  HemS is a potential 
hemin storage/degradation enzyme.  Initial characterization indicates that HemS is able to 
bind hemin in a 1:1 fashion with an estimated dissociation constant (Kd) of 5.9 + 1.7 µM.  
Complementation analyses using Corynebacterium ulcerans CU712hmuO∆ strain have 
not been successful but future experiments plan to use an E. coli chuS strain.  These 
studies have characterized the principal hemin uptake system of B. quintana, identified its 
transcriptional regulator, and initiated investigation of a potential heme oxygenase.      
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CHAPTER ONE 
Introduction to Bartonella quintana and bacterial hemin acquisition 
 
I.  Bartonella quintana  
 
A.  INTRODUCTION 
     The genus Bartonella encompasses 31 species and 3 subspecies of Gram-negative 
facultative intracellular bacteria that belongs to the α2-proteobacterial subclass (See 
Table 1.1, p.18).  To date, eighteen of these species have been solely associated with 
nonhuman mammalian hosts, to date.  Another 10 Bartonella species are implicated in 
occasional reports of human illness suggesting incidental infection.  In contrast, B. 
quintana and B. bacilliformis utilize the human host as the primary mammalian reservoir 
and have been recognized as human pathogens for a long time (89).  Together with B. 
henselae, these three species are the primary Bartonella agents of human disease (122).   
     Alternative mammalian hosts have not been identified for either B. quintana or B. 
bacilliformis, but cats provide an alternative reservoir for B. henselae (121).  Although B. 
henselae has been detected in cat fleas (Ctenocephalides felis), transmission to humans is 
believed to be mediated by the scratch or bite of a cat (189).  Typical B. henselae 
infections in humans result in cat-scratch disease, but complications can include 
endocarditis, bacillary angiomatosis, bacillary peliosis, neuroretinitis and chronic 
bacteremia (56, 121).  Due to the restricted geographical range of its sandfly vector 
(Lutzomyia spp.), infection with B. bacilliformis, which results in Carrion’s disease, is 
less common but more serious than other Bartonella infections (89).  Carrion’s disease 
presents itself in two distinct phases.  The initial phase, Oroya fever, is characterized by 
severe hemolysis-driven anemia and fever.  The next phase, verruga peruana, is 
characterized by the development of vasoproliferative skin lesions (41, 89).  Like B. 
bacilliformis, B. quintana has been described as a ‘specialist’ based on its strict body 
louse vector-human host cycle that lacks an alternative mammalian reservoir (4).  
Transmission to humans is mediated by the human body louse (Pediculus humanus 
corporis), which can also transmit the bacterial pathogens that cause relapsing fever and 
typhus, Borrelia recurrentis and Rickettsia prowazekii, respectively (3).  B. quintana 
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infections cause trench fever and are currently re-emerging as ‘urban trench fever’.  
Complications arising from B. quintana infection, like B. henselae, include chronic 
bacteremia, endocarditis, and bacillary angiomatosis (57).   
 
B.  GENOME AND EVOLUTION 
     The genomes of four Bartonella species, B. bacilliformis, B. henselae, B. quintana, 
and B. tribocorum have been sequenced.  Common themes among all four genomes 
include a core of 959 genes, a G+C content of 38.2 to 38.8%, and a low-coding density of 
72.3 to 81.6% (52).  In addition to being the first recognized pathogenic member of the 
Bartonella genus and the most virulent, B. bacilliformis is thought to represent an ancient 
lineage while the remaining two major Bartonella pathogens, B. henselae and B. 
quintana, along with B. tribocorum appear to have evolved more recently.  The crux of 
this argument is that the ‘modern’ lineage, including B. henselae, B. quintana, and B. 
tribocorum, have genetically acquired factors leading to attenuated virulence and 
improved host adaption.  Genomic analyses indicate that 66 genes required to establish 
intraerythrocytic infection in a rat model are common to all four Bartonella species 
examined.  An additional 15 pathogenicity genes are shared by the representatives of the 
‘modern’ lineage but are absent in B. bacilliformis.  Fourteen of  these 15 genes are 
components of  type IV secretion systems, which allows for the delivery of effector 
molecules into host cells resulting in enhanced host adaptation (151).  The acquisition of 
these factors is a characteristic of the ‘modern’ lineage that may contribute to the 
establishment and maintenance of chronic infections rather than the severe acute phase of 
B. bacilliformis infection. 
     Direct genomic comparisons between B. henselae and B. quintana indicate that the B. 
quintana genome is a reduced version of the B. henselae genome.  Furthermore, both 
genomes appear themselves to be reduced versions of Brucella melitensis chromosome I.  
In particular, B. henselae has a 1.93 megabase pair (Mb) genome containing 1,491 
protein coding genes, 301 of which are unique to B. henselae.   B. quintana has a 1.58Mb 
genome encoding 1,143 proteins, 26 of which are unique to B. quintana (4, 32).  Like B. 
quintana, B. bacilliformis has a small genome consisting of 1.44Mb encoding 1,283 
genes (52).  Reductive genome evolution is consistent with an intracellular lifestyle and 
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vector-borne transmission (32).  In the case of B. quintana and B. bacilliformis, it may 
reflect the utilization by both species of restricted host-range insect vectors and the 
human host.  Alternatively, the genomic expansion observed in B. henselae and B. 
tribocorum may reflect selective pressures unique to the cat and rat reservoirs, 
respectively.         
             
C.  HISTORICAL BACKGROUND 
     Paleomicrobiological methods have been used to amplify B. quintana DNA recovered 
from dental pulp removed from human remains that are estimated to be more than 4000 
years old by radiocarbon dating (45).  Likewise, B. quintana DNA has been recovered 
and amplified from the remains of 7 Napoleonic soldiers and 3 associated body lice found 
in a mass grave in Vilnius, Lithuania.  Local records date the grave to the period of 
Napoleon's retreat from Russia in 1812 (20, 137).  Despite this evidence of its longevity, 
the first published reports describing Trench fever occurred during World War I (WWI) 
(57, 129).  Second only to influenza as a leading cause of illness during WWI, Trench 
fever affected an estimated 1 million soldiers (57, 122).  Signs and symptoms were 
somewhat variable, but typically consisted of possibly relapsing febrile episodes 
accompanied by chills, headache, and body aches with a focus on the shin (177).  The 
end of the war brought with it improved hygienic conditions resulting in decreased 
occurrence of trench fever.  However, World War II (WWII) initiated another round of 
epidemics resulting in continued interest in the causative organism of the disease (119).  
Undoubtedly due to difficulties encountered during attempted in vitro cultivation of the 
organism, B. quintana (then Rickettsia quintana later Rochalimaea quintana) was 
initially thought to be a Rickettsial species (180).   Nonetheless, B. quintana was 
definitively identified as the agent of Trench fever with the fulfillment of Koch’s 
postulates by 1969 (177, 181).  The end of the WWII again brought improvements in 
hygienic conditions that were not conducive to louse infestation or the transmission of 
Trench fever resulting in diminished incidence of and interest in B. quintana that would 
last for more than 2 decades.   
     Interest in B. quintana infections would be renewed again in the 1980s.  Although the 
authors were unaware of it at the time, a 1981 report of Pneumocystis carinii infections in 
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five previously healthy homosexual men marks the first report of AIDS, which is caused 
by the human immunodeficiency virus (HIV) (67).  By 1990, reports of opportunistic 
Bartonella infections in immunocompromised individuals resulting in the development of 
angioproliferative skin lesions similar to the verruga peruana produced by B. 
bacilliformis began to surface.  The condition was called bacillary angiomatosis (BA) 
(109, 142).  B. quintana was isolated from the BA lesions of three HIV-positive 
individuals in 1992 (95).  Within a few years of this report, B. quintana was 
simultaneously reported as a cause of bacteremia and blood culture negative endocarditis 
(BCNE) in homeless populations in Seattle, WA, USA and Marseilles, France (44, 163).  
More than a decade later, B. quintana is widely recognized as a significant re-emerging 
agent of disease especially in inner city homeless populations and immunocompromised 
individuals.   
 
D.  TRANSMISSION 
     B. quintana is found extracellularly in the gut lumen of P. humanus corporis and is 
able to replicate and survive there.  Infection does not affect the longevity of the body 
louse and is not transmitted to louse offspring.  B. quintana is excreted by the louse in a 
biofilm-like matrix in feces where it survives for up to a year.  Lice feed up to five times 
per day on humans and release factors when biting that produce irritation and itchiness.  
Transmission to humans is thought to occur when scratching generates breaks in the skin 
that allow inoculation with the bacteria-laden louse feces (36, 82).  Although uptake 
occurs via an unknown receptor, B. quintana has been identified intracellularly in 
erythrocytes in the human host.  However, only a small percentage of red blood cells 
were found to contain B. quintana in the blood of patients with chronic bacteremia.  No 
evidence of B. quintana-mediated hemolysis or anemia has been found. (145).  B. 
quintana also has a tropism for endothelial cells and is rapidly endocytosed into a vacuole 
where it survives and replicates (26).  The ability of B. quintana to infect erythrocytes 
undoubtedly promotes immune evasion and transmission to the body louse.  Likewise, 
the ability of B. quintana to remain infectious in louse feces for long periods of time 
undoubtedly enhances it transmission to humans.  Thus the transmission cycle is a good 
example of the adaptation of B. quintana to its unique and limited host-vector range.    
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E.  DISEASE AND EPIDEMIOLOGY 
     Re-emerging urban trench fever in HIV-negative individuals was described almost 
simultaneously in the U.S. and France.  Although somewhat variable, signs and 
symptoms similar to classical trench fever were described in primarily homeless, 
alcoholic, male populations.  Chronic bacteremia and endocarditis were also noted in the 
initial reports (44, 163).  Although there were some issues with the species specificity of 
the assay used, followup studies at a downtown Seattle, WA clinic for homeless and 
indigent persons reported that 20% of its subjects were seropositive for B. quintana (83).  
Since that time, numerous studies have been undertaken in order to estimate the 
prevalence of B. quintana in homeless populations.  Of note, the population at-risk for 
urban trench fever and a variety of other infectious diseases, namely the homeless, is by 
its very nature dynamic and difficult to identify, treat, and conduct followup exams on 
(138).  These facts may account for some variability in results.  Alternatively, the 
variability may be the result of environmental factors favoring epidemics at particular 
time points with lower prevalence rates observed between epidemics.  Finally, the studies 
are significantly different from one another in terms of the diagnostic measures and target 
populations.  Collectively these issues result in a fairly wide range of prevalence.  For 
example, a 1997 study of seroprevalence rates with 221 samples taken from eight 
charitable institutions dedicated to the homeless over the course of five months reports 
positive serology in 1.8% of the population (147).  A later study in the same area focused 
on 71 homeless emergency room patients and reported that 14% had positive blood 
cultures for B. quintana and 30% had high antibody titers (25).  During an epidemic 
typhus outbreak in a refugee camp in the East African Republic of Burundi, up to 12% of 
suspected typhoid cases also had increased antibody titers to B. quintana (139).  In a 
2005 Marseilles, France study of 930 subjects from two homeless shelters over the course 
of four years, 22% were infested with body louse and 5.3% were blood-culture positive 
for B. quintana (27).  A wide range of seroprevalence rates have also been obtained in 
U.S. studies.  A 1996 study from Baltimore, MD reported elevated B. quintana antibodies 
in 10% of 630 subjects, while a 2001 study of 204 subjects from New York City found 
only 2% were seroreactive to B. quintana (39, 40).  Yet another study examined 200 
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samples obtained from patients at a downtown Los Angeles clinic and reported 9.5% 
seroprevalence of antibodies to B. quintana (162).  High titers of B. quintana antibodies 
were also reported in 11% of 151 blood samples from homeless people in Tokyo, Japan 
(158). One study focused solely on immunocompromised individuals and found that 
among 382 HIV-positive individuals with a fever of unknown origin, B. quintana or B. 
henselae was the cause in 18% of cases.  The precise number of fevers attributable to B. 
quintana could not be determined due to cross reactivity between the two species in the 
assay (97).  Again, the differences in reported prevalence of B. quintana undoubtedly 
reflect the differences in diagnostic technique, target population, and study design.   
     Another series of studies has examined the prevalence of B. quintana in body lice.  B. 
quintana DNA was amplified by polymerase chain reaction (PCR) in 33% of body lice 
collected from homeless people in Russia in 1996 and 1997 (150).   A recent San 
Francisco, CA study amplified B. quintana DNA from 33% of louse-infested individuals 
and reported an overall rate of 23.9% body louse infestation in 138 participants.  
Interestingly, these authors also amplified B. quintana DNA from head lice obtained in 
the same study even though Bartonella is not usually associated with this subspecies of 
P. humanus (22, 63).  Like seroprevalence rates, a review of a number of these studies 
shows wide variation in the percentage of lice infected with B. quintana.  For example, B. 
quintana was detected in 4-26% of lice from Marseilles, 36% of lice examined in the 
Netherlands, 2.3-93.9% of lice examined in Burundi and only 1.4% of lice in Peru (60).  
Again, the variability observed in different studies may reflect environmental factors 
favoring high rates of infection and transmission. 
     In addition to urban trench fever and chronic bacteremia, B. quintana and B. henselae 
are the primary species responsible for Bartonella-mediated infective endocarditis (IE) 
and are thought to account for approximately 1-3% of all infective endocarditis (16, 59).  
Similarly, one study indicated that Bartonella species account for more than one-fourth 
of blood-culture negative endocarditis cases (BCNE) with B. quintana responsible for 53 
of the 70 cases (79). Serological testing for Bartonella has been suggested as a 
modification to the original Duke criteria used for the diagnosis of IE (111).  Not 
surprisingly, epidemiologic analyses indicate that risk factors for B. quintana-mediated 
endocarditis include exposure to body lice, alcoholism, and homelessness.  This 
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investigation also found that patients with Bartonella-mediated endocarditis were at least 
twice as likely as controls with endocarditis caused by other organisms to require 
valvular surgery and were as likely as controls to have experienced embolic 
complications (59).  Additional life-threatening complications associated with IE include 
congestive heart failure and neurological problems secondary to embolic events (126). 
     Although isolated reports of the disease in immunocompetent individuals exist, 
bacillary angiomatosis is almost entirely associated with immunodeficiences (64, 174).  
Characterized by vasoproliferative lesions containing bacilli observable by Warthin-
Starry staining that can occur in a number of different organs, BA has an estimated 
overall prevalence of 1.2 cases per 1000 HIV-positive individuals (121, 133).  Although 
infection with other Bartonella species can also result in BA, reports suggest that B. 
quintana is the causative agent in just under half of the cases examined.  Furthermore, B. 
quintana, rather than B. henselae, is more likely to be involved in the development of 
subcutaneous and bone lesions (65, 96). 
 
F.  DIAGNOSIS AND TREATMENT 
          Given the extraordinary range of clinical manifestations of B. quintana infection 
and the fastidious nature of the organism, diagnosis and isolation can both be 
challenging.  In cases of suspected urban trench fever and chronic bacteremia, diagnosis 
is typically made by blood culture and serological testing.  Blood culture techniques have 
been marginally successful, but basically consist of either direct plating onto solid media 
or co-cultivation of the sample with cell culture (57, 88).  Even when successful, primary 
isolation of Bartonella can take up to two weeks.   However, refined protocols specific to 
species and tissue sample can enhance Bartonella recovery (57).  Numerous serological 
tests are available including one that was developed and characterized by the Centers for 
Disease Control (CDC).  Problems exist with respect to cross reactivity with other 
species, including Chlamydia pneumoniae and Coxiella burnetti, a lack of anti-Bartonella 
antibody production in up to 25% of blood culture positive HIV-infected individuals, and 
slow development of antibodies to Bartonella in some immunocompetent individuals.  In 
suspected cases of endocarditis and bacillary angiomatosis, additional diagnostic tests 
include PCR and histopathological examination of tissue.  As previously mentioned, BA 
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lesions contain bacilli that can be seen by Warthin-Starry silver staining and clusters of 
bacteria are visible in valvular tissue from Bartonella-mediated endocarditis (57, 88).  
Various PCR targets have been used to differentiate Bartonella species, including but not 
limited to 16S rDNA, the heat shock protein gene htrA, the citrate synthase gene gltA, 
and the 16S-23S rDNA intergenic spacer region (ITS) (121).   
     Although trench fever can be self-limiting, the occurrence of chronic bacteremia in 
homeless people has led to the recommendation that the disease should be treated with 
200 mg of doxycycline by mouth daily for 28 days combined with a 14-day regimen of 
intravenous administration of gentamicin (3 mg/kg body weight).  In the case of bacillary 
angiomatosis, erythromycin or doxycycline (500 mg 4 times daily or 100 mg twice daily, 
respectively) are the drugs of choice and treatment should be maintained for at least 3 
months.  Treatment recommendations for Bartonella-mediated endocarditis consist of 
intravenous administration of gentamicin (3 mg/kg body weight) daily for 14 days (88, 
144).  Risk factors for B. quintana infection include homelessness, alcoholism and 
exposure to body lice.  Providing complete clothing changes, boiling infested clothing 
and sheets, as well as dusting with insecticides, can be used to counter louse infestation.  
Additionally, oral treatment with ivermectin can result in short term decreases in both 
number of lice per infested individual and in prevalence of louse infestation (58, 138).  
With respect to immunocompromised populations and associated B. quintana-mediated 
disease, prophylactic antibiotic treatment is not recommended.  Not surprisingly, 
prophylactic treatment for other infections with macrolides or rifamycin is also effective 
against B. quintana (88).  
 
II.  HEMIN 
 
A.  HEMIN REQUIREMENTS 
     The earliest attempts of in vitro cultivation of B. quintana required media 
supplemented with erythrocytes.  Based on the fact that the red blood cells retained their 
growth enhancing properties even after being subject to freeze/thaw cycles or autoclaved, 
hemoglobin was suspected as the critical factor provided by them.  Examination of B. 
quintana growth as a function of hemoglobin concentration in a blood-agar baser 
 9 
indicated 4 mg/ml was sufficient provided the medium was also supplemented with 
serum (179).  Further analyses indicated that the serum requirement could be fulfilled 
with bovine serum albumin (BSA), which could in turn be replaced with charcoal or 
starch.  Under these conditions, either hemoglobin or high concentrations of hemin (20-
40 µg/ml) were sufficient to support growth.  The authors propose a detoxification role 
for serum and suggest that hemin may be required for hydrogen peroxide breakdown 
(125).  In vitro studies in the closely related species, B. henselae, served to further define 
the precise components of hemin required for growth of Bartonella.  Lactoferrin, 
transferrin, and iron, alone or in combination with protoporphyrin IX, were unable to 
satisfy the hemin requirement suggesting that hemin itself is the essential component of 
erythrocyte lysates for supplying Bartonella with both iron and protoporphyrin IX (152).  
These observations were validated by genomic analyses, which indicate that Bartonella 
species lack most of the enzymes required to synthesize porphyrins.  Ferrochelatase 
catalyzes the addition of iron (II) to protoporphyrin IX to generate heme and is among the 
missing enzymes (4).  The importance of hemin to survival and pathogenesis of 
Bartonella is underscored by in vivo studies that indicate mutagenesis of any of a number 
of proteins involved in hemin acquisition interferes with the establishment of chronic 
intracellular infection of erythrocytes in a rat model (151).  Furthermore, Bartonella 
species have one of the highest reported hemin requirements amongst bacterial 
pathogens.  Notably, a similar concentration of hemin is required for growth of some 
Haemophilus species that also lack porphyrin biosynthesis pathways (172).   
 
B.  HEMIN AVAILABILITY  
      Heme is a required component of a number of proteins vital to cellular function in 
pathogen, vector and host.  For example, it is a key component of cytochrome c, 
myoglobin, nitric oxide synthase, prostaglandin synthase, and hemoglobin.  In fact, 
hemoglobin is the most abundant protein in blood and hemoglobin-bound heme 
concentrations are approximately 10 mM (68).  However, free hemin is toxic in excess 
due in part to its hydrophobic nature that allows it to disrupt membrane and cytoskeletal 
interactions.  Additionally, the iron moiety of heme is able to participate in Fenton 
chemistry resulting in the generation of reactive oxygen species (ROS).  Accordingly, 
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incubation with free hemin can result in protein oxidation leading to cross-linking and 
aggregation, lipid peroxidation, single-strand DNA scission or nicking of DNA and 
subsequent degradation.  Likewise, bloodstream hemoglobin can be oxidized to 
methemoglobin by activated inflammatory cells resulting in an enhanced release of 
hemin and all of its associated toxicities (11).  A number of strategies exist to limit heme-
mediated cytotoxicity.  One strategy, employed by bacteria, humans and number of other 
organisms, is the breakdown of heme into biliverdin, free iron (Fe 
2+
) and carbon 
monoxide (CO) by heme oxygenases.  Another strategy is the production of high-affinity 
scavenger proteins such as haptoglobin, which binds hemoglobin, and hemopexin, which 
binds heme, thereby neutralizing their ability to cause cellular damage (103).  Serum 
proteins such as transferrin and lactoferrin are also produced to sequester free iron and 
prevent its participation in the generation of damaging reactive oxygen species (103).  
Exacerbating the iron and hemin limitation in the human host and underscoring its 
importance to the survival and pathogenesis of bacteria is the fact that iron sequestration 
is an innate immune response to infection.  Mechanisms include decreasing absorption of 
dietary iron, increasing serum concentrations of transferrin, increased production of 
hemoglobin, haptoglobin and hemopexin, and localized release of lactoferrin by 
neutrophils (7, 112).  The hemoglobin/hemopexin scavenger receptor, CD163, is released 
from the cell surface as a soluble molecule and cell surface expression is subsequently 
upregulated in response to lipopolysaccharide- and bacterial flagellin-mediated activation 
of Toll-like receptors (185).      
     In contrast to the human host, little is known about the fate of hemoglobin in the louse 
gut during digestion of a blood meal.  It is generally accepted that blood-sucking 
arthropods face a unique challenge with respect to hemin detoxification as either free or 
bound hemin is thought to exceed 5 mM during digestion of a blood meal (68).  Although 
the mechanisms employed by P. humanus are not known, several adaptations have been 
reported in other hematophagous insects.  Several reports suggest that certain ticks digest 
hemoglobin intracellularly (1, 107).  In contrast, some mosquitoes and other insects 
sequester heme in the gut lumen by surrounding it with extracellular matrix proteins or 
phospholipids membranes.  Alternatively, they may surround the gut cells with a 
protective matrix (107).   
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C.  HEMIN UPTAKE SYSTEMS 
     Utilization of host hemin-containing proteins as a source of both hemin and iron is a 
common strategy employed by successful pathogens.  In fact, recent studies in 
Staphylococcus aureus indicate that hemin is preferred over transferrin as an iron source 
(161).   Both classical and unique heme uptake systems have been characterized in 
several bacterial pathogens.  At least two common solutions to the heme uptake problem 
exist in Gram-negative bacteria.  The first is the use of outer membrane receptors that 
directly bind heme or heme-containing proteins (See Fig. 1-1A, p. 19).  Heme receptors 
are further subclassified on the basis of substrate specificity.  For example, the BhuR 
receptor of Bordetella avium has been classified in the ‘heme scavenger’ receptor 
category based on its ability to use hemin, hemoglobin, myoglobin and catalase while the 
HmbR receptor of Neisseria meningitidis is in the more specific hemoglobin subclass 
based on its limited ability to obtain heme from other hemoproteins (124, 132).   
     The second common solution combines the utilization of outer membrane receptors 
with secreted high affinity hemophores.  Hemophores obtain heme from hemoproteins in 
the vicinity and deliver it to the appropriate receptor.  A classic example of this solution 
is the recently crystallized HasA/HasR system of Serratia marcescens (See Fig. 1-1B, p. 
20).  Crystallographic data indicate that the transfer of heme from the high affinity 
hemophore, HasA, to the lower affinity receptor, HasR, is mediated by a small steric 
hinderance upon completion of docking that dislodges the heme from HasA (102).  
     In either scenario, once heme is bound to the outer membrane receptor it is transported 
into the cell by virtue of a periplasmic binding protein and an ATP binding cassette 
(ABC) transport system.  Heme is slightly larger than the upper threshold size of 
molecules able to diffuse across membranes but has been shown to transverse model lipid 
bilayers (66).  Regardless, heme transport across the outer membrane is energy-
dependent and that energy is obtained from the proton motive force of the inner 
membrane through the TonB/ExbB/ExbD complex.  TonB is in direct contact with 
receptors through its C-terminal domain and its N-terminal domain is in contact with 
ExbB and ExbD.  The complex is thought to bind protons used to energize TonB through 
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conformational changes, which are then transduced to the outer membrane through 
interaction with a weakly conserved amino acid consensus sequence found in TonB-
dependent receptors termed the TonB box (172).  TonB-dependent receptors share 
structural similarity; they consist of 22 anti-parallel β-strands and share an N-terminal 
plug (102).  Additionally, heme receptors share a certain amount of amino acid sequence 
similarity including conservation of the characteristic FRAP/NPNL domain (183).   
     The fate of heme upon entering the cytosol is unclear.  Most heme uptake loci from 
bacterial pathogens include a putative heme degrading/storage enzyme.  In some species, 
e.g. E. coli O157:H7, these enzymes have been shown to function as heme oxygenases 
while homologous proteins in other bacterial pathogens have been described as heme 
chaperones or storage molecules  (90, 169, 193).   
     Genomic analyses of B. quintana indicate the presence of at least three systems with 
the potential for involvement in heme or iron uptake (4) .  One of these is the hut locus, 
encoding a potential hemin receptor and a coordinate ABC transporter system (discussed 
in detail in Chapter 3).   A second locus, designated yfe (A-D), encodes a putative ABC 
transporter implicated in manganese, zinc, and possibly ferric iron acquisition, but lacks a 
homolog to yfeE.  YfeE is an essential component of the system in Yersinia pestis, as 
evidenced by its requirement for complementation of an E. coli strain unable to produce 
the enterobactin siderophore (15).  The final locus, fatB-D, encodes a putative 
siderophore transporter system similar to that described in Vibrio species (113).  Notably, 
B. quintana also encodes a five member family, HbpA-E, of porin-like proteins that have 
been shown experimentally to bind hemin despite the absence of structural or sequence 
similarity to classical hemin receptors (discussed in detail in Chapter 2) (31, 123).   
 
D.  REGULATION OF HEMIN UPTAKE 
     Like mammalian cells, bacteria are also sensitive to iron- and hemin-mediated 
oxidative damage.  Therefore, survival of bacterial pathogens requires a balance between 
obtaining sufficient iron and heme in the limiting environment of the human host such 
that required levels are available and preventing the accumulation of intracellular 
concentrations high enough to cause injury.  Furthermore, B. quintana must be able to 
rapidly shift between the iron-replete louse gut and the iron-deficient human host.  
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Numerous examples of iron-responsive transcriptional regulation exist in the literature.  
Although homologs exist in many bacterial species, the ferric uptake regulator (Fur) of E. 
coli is the most well studied example.  Under iron-replete conditions, dimeric Fur binds 
ferrous iron (Fe
2+
), which causes a conformational shift that allows binding to a 
consensus sequence (Fur box) and repression of target genes (28).  Reports confirming 
the role of Fur as a “global” iron responsive regulator are primarily associated with other 
members of the γ-proteobacterial subclass.  A Fur homolog exists in all pathogenic 
Bartonella species, and its role will be discussed in detail in Chapter 2 (131).  
     In species more closely related to Bartonella, such as Agrobacterium and Rhizobium, 
the function of  Fur has been largely delegated to novel iron response proteins, namely 
the iron response regulator (Irr) and/or the rhizobial iron regulator A (RirA) (71, 148, 
190).  RirA has primarily been characterized in α-proteobacteria and appears to be an 
iron-sulfur cluster regulator (IscR).  Mutational analyses suggest that it can function as 
either a transcriptional activator or a repressor and target genes include transport systems 
involved in hemin and iron acquisition (148, 171, 178).  The B. quintana RirA 
homologue has 85% amino acid similarity to R. leguminosarum RirA. 
     Irr is a member of the Fur family, but responds directly to intracellular hemin 
concentrations rather than iron and can either transcriptionally activate or repress genes 
depending on the location of its cognate DNA consensus motif (71, 149).  In 
Bradyrhizobium japonicum, Irr is transcriptionally regulated by Fur and post-
translationally regulated by hemin, which rapidly degrades the protein upon binding to it 
via two heme response motifs (HRM) (194).  In contrast, the Brucella abortus Irr 
homolog remains stable even upon heme binding (117).  Irr has been shown to repress a 
number of genes, including those involved in protoporphyrin biosynthesis under iron-
limiting conditions.  Positive regulation of both heme and iron uptake systems has been 
reported (117, 149).  The B. quintana Irr protein has 72% amino acid similarity to B. 
japonicum Irr.  The precision and speed required for B. quintana to react to shifts in 
available hemin as well as the number of systems dedicated to the uptake of this critical 
factor suggest a complex regulatory network requiring one or more of the aforementioned 
regulators to fine tune uptake and detoxification systems.   
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E.  IRON/HEMIN-MEDIATED REGULATION OF VIRULENCE 
     Iron and hemin limitation in the human host serve as environmental triggers for the 
expression of virulence factors in many bacterial pathogens.  For example, the expression 
of Shiga-like toxin (SLT-1), which interferes with eukaryotic ribosomal function, is 
repressed by Fur in enterohemorrhagic E. coli strains.  Exotoxin A of Pseudomonas 
aeruginosa is also under Fur control, albeit indirectly through the Fur-regulated 
alternative sigma factor, PvdS (80).  A classic example of iron-regulated expression of 
virulence factors  is the diphtheria toxin from Corynebacterium diptheriae, which is 
under control of the DtxR regulator (112).  DtxR also controls siderophore biosynthesis 
and hemin uptake in Corynebacterium (188).  Although the implications are not clear, a 
recent study examining lipid A heterogeneity in Porphyromonas gingivalis indicates 
increased production of monophosphorylated tetra-acylated and diphosphorylated penta-
acylated lipid A when the organism was grown in media containing high (10 µg/ml) 
concentrations of hemin compared to the production of only monophosphoryl penta-
acylated lipid A when grown in the presence of 1 µg/ml.  Of note, lipopolysaccharide 
(LPS) containing penta-acylated lipid A has been shown to act as a Toll-like receptor 4 
(TLR4) agonist (2).  Another recent study examining alterations in gene expression in 
response to iron limitation in Bacillus anthracis reported the induction of two putative 
internalin genes.  Although the function of these genes is not precisely defined, a 
homolog in Listeria monocytogenes has been implicated in epithelial cell invasion.  The 
role of these genes in B. anthracis virulence was established when deletion of either or 
both internalin genes resulted in a substantial increase in the number of spores required to 
kill half of the mice tested (LD50) (30).  These examples indicate that the shift to low iron 
and hemin is frequently an indicator of host invasion to pathogens and results in 
coordinate control of factors required for virulence.   
 
 
III.  RESEARCH SIGNIFICANCE AND GOALS 
 
A.  SIGNIFICANCE 
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     Hemin is a critical factor for the growth of Bartonella but the mechanisms employed 
to obtain it, the regulatory networks controlling those mechanisms and the basis of the 
extraordinary requirement remain elusive.  Reports describing the Hbp family members 
as potential heme receptors combined with identification of a Fur homolog in Bartonella 
provided much of the impetus for the current studies (123).  The lack of structural 
similarity to known heme receptors makes the role of the Hbps in heme acquisition truly 
intriguing.  Identification of HbpE as one of the predominant proteins recognized by 
convalescent sera from patients infected with B. quintana indicates a role virulence and 
pathogenesis (23). Bartonella species are currently recognized as emerging agents of a 
number of human diseases ranging from self-resolving flu-like diseases to life threatening 
endocarditis, but very little is known about mechanisms of pathogenicity.  Furthermore, 
Hbp homologs exist in several bacterial species, including Brucella and Neisseria (123).  
Therefore, any further definition of Hbp function has the potential to be generalized to a 
number of important pathogens. Likewise, not only do Bartonella species exhibit an 
absolute requirement for heme in order to grow in vitro, one species has been used to 
show that both HbpB and several components of the hut locus are required to establish 
intracellular infection in vivo (151).  Delineation of the roles of the Hbps and the hut 
locus proteins is significant because it will either expand or validate the current paradigm 
of hemin acquisition in Gram-negative bacterial pathogens.  Bacterial hemin acquisition 
systems are an attractive target for rational drug design because inhibition of these 
systems is likely to be synergistic with the innate immune response and lethal for the 
pathogen.   
     Regulatory networks in Bartonella are largely undefined.  Regulation of heme 
acquisition is significant in and of itself, but as argued previously many virulence factors 
are under transcriptional control of iron-responsive regulators.  Given the enormous 
differences in heme availability thought to be encountered by B. quintana in the human 
host and body louse vector, environmental heme concentrations may serve as an even 
more potent cue indicative of the host environment in this species than it is in others.  
Iron-responsive regulation in Gram-negative bacteria has primarily been attributed to the 
Fur protein owing to the fact that the majority of studies have been done in E. coli.  
Identifying Fur targets in Bartonella and examining the activity of the less well known α-
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proteobacterial regulators Irr and RirA will be an important first step in defining the 
regulatory network of this hemotrophic bacterium.  On a more concrete and practical 
level, these studies may begin to characterize inducible species-specific promoters with 
potential utility in genetic manipulation. 
     Finally, the fate of heme upon delivery to the cytoplasm by classical heme uptake 
systems is not precisely known.  Heme oxygenases (HO) have been identified in 
mammalian cells; bacterial HOs have various levels of homology to them (62, 156).  
Recent reports suggest that the HemS homolog in E. coli, ChuS, is a unique HO (169).  
This is in direct contrast to reports in other bacterial species that suggest that this protein 
stores, protects, or transports heme.  While these multiple functions are not necessarily 
exclusive, no reports of overlapping function exist.  The function of this protein is of 
particular interest in B. quintana because examination of the genome suggests that this 
organism does not possess any sort of iron storage protein, e.g. bacterioferritin (Minnick 
and Battisti, unpublished data).  Iron acquisition per se has not been described in 
Bartonella beyond reports indicating that iron alone is insufficient for in vitro growth 
(152).  Even if independent iron uptake systems exist, free iron outside of the heme 
molecule, or perhaps hemosiderin, is unlikely to be abundant in an erythrocyte.  It seems 
likely that heme serves as both the porphyrin source and the iron source in B. quintana, 
suggesting the necessity of a heme oxygenase.  Of additional importance, ChuS is 
notably absent from avirulent strains of E. coli and homologous proteins are present in 
the genomes of many bacterial pathogens (169).  Regardless of the mechanism used by 
these proteins to neutralize heme, it undoubtedly contributes to the pathogens' ability to 
colonize the mammalian host.  Like other components of bacterial heme uptake systems, 
ChuS-like enzymes represent an attractive target for the rational design of antimicrobial 
peptides in part due to the absence of similarity to mammalian heme oxygenases.               
 
B.  RESEARCH GOALS 
     These studies were undertaken to elucidate the mechanisms and regulation of heme 
acquisition in B. quintana.  Initial experiments focused on the Hbps and Fur.  Based on 
descriptions of Fur as a ‘global’ iron-responsive regulator, the first goal was to determine 
the function of B. quintana Fur by complementation of an E. coli fur strain.  The ability 
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of the Hbps to bind hemin and confer a hemin-binding type on E. coli was well 
established, but expression profiles in response to alterations in available heme were not 
defined.  Therefore, the second goal was to examine hemin-mediated regulation of B. 
quintana HbpA.  The third goal was to examine the effect of B. quintana Fur on hbp 
transcription.  However, difficulties in identifying natively expressed Fur led to the 
modification of this goal such that it became an attempt to identify expression of B. 
quintana Fur by either in vitro transcription/ translation (IVTT) or Western blotting.  The 
HbpA homolog, Pap31, in B. henselae was shown to function as a hemin receptor by 
complementation analyses in an E. coli hemA strain (199).  The fourth goal was to 
examine the ability of HbpA to similarly function as a hemin receptor by 
complementation analyses.   
     The second set of experiments focused on characterizing the function and regulation 
of the B. quintana hut locus.  The primary goal of this set of experiments was to examine 
the ability of HutA to function as a hemin receptor by complementation analysis of the E. 
coli hemA strain EB53.  Classical heme receptors are typically TonB-dependent.  The 
ability of HutA to function as a heme receptor in an otherwise isogenic E. coli strain with 
a second mutation in tonB was also tested by complementation analyses.   A secondary 
goal of these studies was to establish heme-mediated transcriptional regulation of the hut 
locus and to examine the effects of each of the potential iron-responsive regulators, 
namely Fur, Irr, and RirA, on the transcriptional profile of the hut locus genes.  
Additionally, these experiments were performed with RNA isolated in parallel from three 
different hemin concentrations in order to account for cofactor availability.  This was 
accomplished by quantitative reverse transcription-polymerase chain reaction (qRT-
PCR).  A third goal was to define the transcriptional organization of the hut locus and this 
was accomplished by RT-PCR.  The final goal of the experiments was to map the 
transcriptional start sites (TSSs) of the transcriptional units in order to identify putative 
promoter and regulatory binding sequences.   
     The final set of experiments undertaken has focused on characterization of the B. 
quintana HemS protein.  The first goal of these experiments was to generate and purify a 
natively-folded His-tagged HemS.  The second goal of these experiments was to examine 
the ability of the purified recombinant HemS protein to bind hemin.  This goal was 
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achieved spectrophotometrically and by hemin blotting.  The third goal of these studies 
was to examine the ability of B. quintana HemS to function as a HO in a 
Corynebacterium ulcerans hmuO mutant by complementation.  The final goal of these 
experiments was to examine the ability of recombinant HemS to catalyze the breakdown 
of hemin in vitro.   This goal was approached spectrophotometrically.        
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Table 1.1.  Bartonella species and their ability to cause human disease. 
                                                                                                                                                      
Species           Vector      Reservoir    Reference(s)           Disease  Reference(s)   
alsatica        Unknown       Rabbit       (75)               Isolated   (85) 
australis        Unknown       Kangaroo        (61)               No 
bacilliformis        Sandfly       Human       (36)               Oroya fever   (89) 
birtlesii        Unknown       Mouse       (18)               No 
bovis         Horn fly (?)    Cattle       (17, 38)       No 
capreoli        Tick (?)       Roe Deer       (17, 21)        No 
chomelii        Unknown       Cattle              (114)               No 
clarridgeiae        Flea (?)       Cat                   (110, 144)               Isolated   (98, 
115) coopersplainsensis Unknown       Rodent       (70)    No 
doshiae        Flea       Rodent       (20, 170)      No 
elizabethae        Flea (?)       Rodent, Dog    (49, 50, 116)   Isolated   (42, 
130) 
grahamii        Flea       Cat                   (20, 170)      Isolated   (93) 
henselae        Flea, Cat       Cat                   (89)    Cat Scratch   (6, 
89) 
japonica        Unknown       Rodent       (81)    No 
kohlerae        Flea, Cat       Cat                   (47, 146)      Isolated   (9) 
peromysci        Unknown       Rodent       (20)    No 
phoceensis        Unknown       Rodent       (69)    No 
queenslandensis     Unknown       Rodent       (70)    No 
quintana        Body louse     Human       (89)    Trench fever   (89) 
rattaustraliani        Unknown       Rodent       (70)    No 
rattimassiliensis     Unknown       Rodent       (69)    No 
rochalimae        Unknown       Human (?)       (53)    Isolated   (53) 
schoenbuchensis    Deer ked       Deer       (118)    No 
silvatica        Unknown       Rodent       (81)    No 
tamiae         Unknown       Rodents (?)      (100)    Yes    (100) 
taylorii        Flea       Rodent       (20, 170)     No 
tribocorum        Flea       Rodent       (76, 141)     No 
talpae         Unknown       Moles       (20)     No 
vinsonii 
sub sp. aurepensis  Unknown       Rodent       (187)     Isolated   (54) 
sub sp. berkhoffi    Ticks (?)       Dog, Coyote    (34, 77, 99)    Isolated   (24) 
sub sp. visonii        Unknown       Vole       (99)     No 
washoensis        Ticks (?)       Dog, Squirrel   (34, 37, 101)    Isolated   (134) 
weissi         Unknown       Cat         (196)          No 
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A) 
 
Figure 1-1.  Schematic of bacterial hemin acquisition systems.  A)  Model of hemin 
acquisition via an outer membrane (OM) hemin receptor and a coordinate transport 
system as described in Bordetella (175).  BhuR is a hemin receptor that uses energy 
transduced by TonB and ExbB/D to bring hemin into the periplasmic space (PS).  BhuT 
is a periplasmic binding protein that shuttles hemin to the membrane-spanning permease, 
BhuU.  Energy for hemin transport across the inner membrane (IM) is provided by the 
ATPase activity of BhuV.  The fate of hemin in the cytoplasm is uncertain.  Predicted 
functions for BhuS and its homologs include storage or degradation of hemin.  B) Model 
of hemin acquisition via a hemophore as described in Serratia marcescens (33).  The 
hemophore HasA is secreted and binds hemin with high affinity.  The hemin-HasA 
complex docks onto the hemin receptor, HasR, and releases hemin for transport into the 
cytoplasm as described in A.   
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CHAPTER TWO 
Hemin Uptake Is Not Mediated by Hemin Binding Protein A and the Ferric Uptake 
Regulator Is Not Central to Iron-Responsive Regulation in Bartonella quintana 
 
 
A.  INTRODUCTION 
     Bartonella quintana has an extraordinary heme requirement that is thought to fulfill 
both iron and porphyrin needs.  B. quintana is expected to have evolved specialized 
systems adept at satisfying this requirement despite the heme-limiting nature of the 
human host environment.  In addition to its success as a human pathogen, B. quintana is 
also able to rapidly shift between the human host and the heme-replete gut of the body 
louse.  Thus, B. quintana must not only be able to acquire heme when it is scarce, but 
must also be able to protect itself from heme-mediated toxicities when heme is abundant.  
Therefore, the expression of heme uptake systems in B. quintana is expected to be under 
tight iron- and/or heme-responsive control.  The disparity in heme availability between 
these two environments suggests that heme concentration may also serve as an indicator 
of the shift into either the human host or the body louse.  Consequently it would be 
logical to co-regulate heme acquisition and virulence, as described in numerous other 
bacterial pathogens.  Despite the pivotal role of heme to the survival and pathogenesis of 
B. quintana, little is known about either the mechanisms or the regulation of heme 
acquisition in this versatile species.   
      Iron-responsive regulation in Gram-negative bacteria is primarily attributed to the 
ferric uptake regulator (Fur) and has been most widely studied in E. coli.  In the presence 
of excess iron, the dimeric Fur protein binds the ferrous form (Fe
2+
) and undergoes a 
conformational shift.  The Fur dimer then binds DNA at a consensus motif, 
GATAATGATAATCATTATC, in the promoter region termed the Fur Box and represses 
transcription (164).  Fur has also been implicated in the activation of genes, but the 
mechanisms may involve the regulation of intermediate regulators and/or post-
transcriptional control.  Fur-targeted genes encode iron and heme uptake systems, 
superoxide dismutase, and several virulence factors.  In fact, more than 90 genes are 
regulated by Fur in E. coli (72).  Fur homologues have been identified in several Gram-
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negative pathogenic genera including Yersinia, Vibrio, Neisseria, Salmonella and 
Haemophilus (143).  Although it only has 38% amino acid identity to E. coli Fur, a Fur 
homologue was also identified in B. henselae (131).  Corresponding fur genes were also 
identified in B. bacilliformis and B. quintana (131).  Functional analyses of B. henselae 
fur indicate that it was able to complement a Vibrio cholerae fur mutant when 
constitutively expressed by a ptac promoter (131).  Based on these data, we hypothesized 
a major role for B. quintana Fur in transcriptional control of heme acquisition systems. 
     The heme acquisition systems of B. quintana have not been fully characterized, but 
studies to date have focused on the genes encoding hemin-binding protein (Hbp) family 
members as a potential Fur target.  This family consists of five porin-like outer 
membrane proteins (HbpA-E) that share ~ 48% amino acid identity to one another and 
are able to bind hemin, as implied by the name.  Structural predictions suggest that each 
Hbp forms a β- barrel consisting of eight conserved transmembrane domains connected 
intracellularly by four small loops and extracellularly by four large loops (123).  Out of 
eight membrane proteins identified by hemin blots, HbpA was chosen for further 
investigation because it was the only protein that hemin remained bound to after the blot 
was extensively washed (31).  Pretreatment of B. quintana with α-HbpA antibody 
fractions was sufficient to partially inhibit heme binding relative to controls.  Although 
recombinant HbpA was unable to confer a hemin-binding phenotype on E. coli, analysis 
of a B. quintana hbpA mutant showed increased hemin binding relative to wild type.  
Correspondingly, quantitative reverse-transcriptase-PCR (qRT-PCR) examining 
expression profiles of the remaining hbp transcripts in the B. quintana hbpA mutant 
indicated that compensatory expression occurred with all remaining members of the 
family upregulated to some degree.  Of note, a sequence was identified in the promoter 
region of the hbp genes that shares ~50% identity to the Fur Box of E. coli suggesting a 
role for the B. quintana Fur protein in transcriptional control.   
     HbpA shares amino acid similarity with an outer membrane protein from Brucella, 
Omp31, the Opa proteins from Neisseria, and the phage-associated protein, Pap31, from 
B. henselae (123).  Examination of the hemin-binding capacity of Brucella suis or B. ovis 
Omp31 indicates that it also binds hemin.  As described with HbpA, pretreatment of B. 
ovis with α-Omp31 antibodies inhibits heme binding.  Moreover, Omp31 expression is 
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increased when B. suis is grown on iron-deficient media relative to the amount produced 
when the strain is grown on iron-replete media (43).  The hemin-binding capacity of 
these proteins is extended in the characterization of Pap31 from B. henselae.  
Investigation of this HbpA homolog focused on its ability to function as a hemin receptor 
in an E. coli hemA mutant, EB53, which is unable to synthesize porphyrin.  As the 
parental strain is relatively impermeable to the heme molecule, there are only two ways 
for this strain to obtain hemin.  The first is to bypass the hemA mutation with the addition 
of δ-aminolevulinic acid (the product of the reaction catalyzed by HemA) and the second 
is to express a recombinant hemin receptor so that hemin can be imported from an 
external source.  These experiments indicated that expression of recombinant Pap31, 
consisting of the sequence encoding the mature protein fused to the signal sequence from 
ompT of E. coli, was sufficient to allow growth of EB53 in the presence of exogenous 
hemin (199).  Together, these data led to the hypothesis that HbpA functioned as a hemin 
receptor in B. quintana, that Hbp expression was responsive to available hemin and/or 
iron concentrations, and that this response was mediated at least in part by the Fur 
protein.       
     These studies were undertaken to examine these hypotheses and define the major 
mechanisms and regulation of hemin acquisition in B. quintana.  Here, we report that 
although B. quintana HbpA expression is responsive to available hemin concentration, 
expression of the recombinant protein in EB53 is insufficient to reproducibly 
complement the hemA strain.  Furthermore, while forced B. quintana fur expression is 
able to complement an E. coli fur mutant, we were unable to identify an endogenous 
promoter in the B. quintana fur gene or express the native protein.   
 
B. MATERIALS AND METHODS 
 
     Bacterial strains and growth conditions.  E. coli strains were routinely grown 
overnight at 37
o
C with shaking in either Tryptone-yeast extract (TY) and lysogeny broth 
(LB) media and standard antibiotic concentrations were added as needed.  25 µM δ-
aminolevulinic acid (ALA) (Research Products International, Prospect, IL) was added to 
the medium for growth of E. coli hemA strain EB53 (51).  Induction of gene expression 
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was achieved with isopropyl-β-D-thiogalactopyranoside (IPTG) at a concentration of 2 
mM.  B. quintana strains were cultivated on heart infusion blood agar (HIAB) or on 
Brucella agar (BA) supplemented with 6 µM to 2.5 mM hemin chloride (Becton 
Dickinson, Sparks, MD).  Cultures were grown at 37
o
C in 100% relative humidity and 
5% CO2 (12).  10 mg/mL stock solutions of hemin chloride in 0.2 M NaOH were filter 
sterilized prior to use.  Table 2.1 (p. 34) lists the strains used in this study.   
 
     Preparation and manipulation of DNA.  All plasmids used or generated in this 
study are listed in Table 2.1 (p. 34), and all primers used in this study are listed in Table 
2.2 (p. 35).  Genomic DNA from B. quintana and E. coli was obtained with a DNeasy 
blood and tissue kit (Qiagen, Valencia, CA) per protocol.  Plasmids used for restriction 
analysis and sequencing were purified with a Perfect Prep plasmid minikit (Eppendorf, 
Hamburg, Germany) and those used for electroporation and in vitro 
transcription/translation were purified with a Qiagen Midi-Prep kit (Valencia, CA).  
Standard procedures were used for ligations, cloning, restriction endonuclease digestion 
and analyses, and polymerase chain reaction (PCR) (8).  When appropriate, a QIAquick 
spin kit was used for purification of PCR amplicons and extraction of DNA from excised 
agarose gel slices (Qiagen).  Fusion of the mature B. quintana hbpA gene with the E. coli 
ompT signal sequence was generated by overlap extension PCR as previously described  
(78).  The fusion was cloned into the low-copy plasmid pWSK29 (184). 
 
     Generation of anti-Fur antisera.  A his6-tagged B. quintana Fur protein was 
generated and purified under denaturing conditions per QIAexpressionist protocol 
(Qiagen).  Separation of purified protein fractions was accomplished with sodium 
dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) using 12.5% (wt/vol) 
acrylamide.  Unfixed gels were washed three times (5 min each) with deionized water 
(dH2O), stained with 0.05% Coomassie Brilliant Blue R-250 (Fisher Scientific, Fair 
Lawn, N.J.), and destained with dH2O.  Purified Fur bands were excised, combined and 
used to generate polyclonal anti-Fur antiserum in a female New Zealand White rabbit 
(154).  
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     Hydrogen peroxide treatment of B. quintana.  In an effort to upregulate Fur 
expression, B. quintana was treated with hydrogen peroxide (H2O2) basically as 
described previously (197).  Briefly, three plates of mid-log phase B. quintana were 
harvested, pelleted (2,300 x g for 10 min at 4
o
C) then resuspended in 1 ml Brucella broth 
supplemented with histidine-hematin (BBH-H50) (50 µg/ml) (35).  H2O2 was added to a 
final concentration of 50 mM.  200 µl samples were removed at time 0, 10 min, 60 min 
and 120 min.  Cells were pelleted (15,700 x g for 20 sec at room temperature (RT)), 
resuspended in 100 µl sterile dH2O, and placed in a -80
o
C ethanol bath until needed. 
 
     Complementation analyses.  Various plasmids containing B. quintana fur were 
assayed for functional expression using E. coli fur strain H1780.  Strains were plated onto 
MacConkey agar supplemented with 100 µM FeCl3 and appropriate antibiotics, then 
incubated overnight at 37
o
C.  The ability of B. quintana Fur to repress β-galactosidase 
activity was assessed by color:  Lac
+
 Fur
-
 strains produced red colonies and Lac
-
Fur
+
 
strains produced clear colonies as previously described (73).  Complementation assays of  
E. coli hemA strain EB53 with B. quintana (ompTSS) hbpA were performed basically as 
described (199).  In brief, cultures were grown overnight, then pelleted and grown for ~2 
hours in TY media lacking δ-aminolevulinic acid to exhaust intracellular porphyrin 
stores.  Cultures were then used to inoculate TY media alone, supplemented with ALA 
(50 µM), or hemin (10 µg/ml or 50 µg/ml) to an initial optical density at 600 nm (OD600) 
of 0.02.  Growth curves were generated by measuring the OD600 every four hours for 24 
hours.   
 
     In vitro transcription/translation.  The B. quintana fur gene and successively larger 
portions of the upstream secA gene were directionally cloned in either the same 
orientation or the opposite orientation to the lacZ promoter of either pCR2.1 TOPO or 
XL-TOPO in order to map the fur promoter.  The E. coli S30 extract system for circular 
DNA (Promega, Madison, WI) and a S-35 Express (cysteine-methionine) mix (New 
England Nuclear-Dupont, Boston, MA) were used for translation and radiolabeling of the 
proteins.  Products were separated by SDS-PAGE using 12.5% (wt/vol) acrylamide gels 
that were subsequently dried and exposed to X-ray film for up to 96 hours.   
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     Sarkosyl fractionation, proteinase K treatment, and immunoblotting.  Overnight 
cultures of E. coli were harvested, washed in phosphate-buffered saline (PBS pH 7.4) and 
resuspended in dH2O.  Cells were lysed with a FP120 Fast Prep bead homogenizer (45 s 
at top speed) using 0.1 mm zirconia beads (Qbiogene, Carlsbad, CA).  Cell lysates were 
incubated in 2% (wt/vol) N-lauroyl sarcosinate (Sigma, St. Louis, MO) for 30 min and 
then centrifuged at 4
o
C for 60 min at 100,000 x g.  The sarkosyl-soluble supernatant was 
removed and the insoluble pellet was resuspended in 0.2 mM phenylmethanesulfonyl 
fluoride (PMSF) in dH2O.   
     Surface accessibility of recombinant HbpA was also confirmed by proteinase K 
treatment with slight modifications to previously described methods (120).  Briefly, cells 
were pelleted, washed three times with PBS supplemented with 0.9 mM MgCl2 and 1.0 
mM CaCl2 (PBS MgCl2/CaCl2), and enumerated with a LIVE/DEAD BacLight bacterial 
viability kit (Invitrogen, Eugene, OR).  Live cells were diluted to 10
9
 cells/ml and treated 
with 0-1500 µg/ml proteinase K for 10 min at room temperature.  The reaction was 
stopped by the addition of 200 µg of PMSF in isopropanol.  Cells were pelleted and 
washed two more times with PBS MgCl2/CaCl2.  A bicinchoninic acid kit was used to 
determine protein concentrations (Pierce, Rockford, IL).  Samples were separated by 
SDS-PAGE and resulting gels were transferred to nitrocellulose (GE Water & Process 
Technologies, Trevose, PA) for Western blotting (173).  Blots were probed overnight 
with either rabbit anti-HbpA (1:5000) or anti-Fur (1:500) antiserum and developed with 
hydrogen peroxidase-conjugated secondary antibodies (Sigma), 4-chloronapthol, and 
hydrogen peroxide.  Fur protein expression was also probed with anti-E. coli Fur antisera 
(A generous gift from M. Vasil) at a 1:500 dilution for 2 hours, then developed (as 
described above).   
 
C.  RESULTS 
 
     Complementation of E. coli fur strain H1780.  The E. coli fur mutant H1780 has a 
lacZ fusion under control of the fur promoter that allows iron-mediated control of β-
galactosidase production when a functional Fur protein is provided in trans (73).  In order 
 28 
to test the hypothesis that B. quintana fur encodes a functional ferric uptake regulator, a 
construct containing B. quintana fur under control of the plasmid-encoded lac promoter 
was generated and used to transform E. coli strain H1780.  The resulting strain, along 
with a control consisting of H1780 transformed with vector alone, was tested for its 
ability to repress β-galactosidase production when grown on iron-rich MacConkey 
medium.  MacConkey medium contains lactose and a pH indicator such that production 
of β-galactosidase results in the generation of lactic acid which makes colonies appear 
red, while repression of lacZ results in the generation of whitish-yellow colonies.  Results 
from these experiments indicate that B. quintana fur is able to repress lacZ in H1780 
when grown in the presence of 100 µΜ FeCl3, as evidenced by the production of white 
colonies on the left half of the plate in Figure 2-1 (p. 37).  Likewise, transformation of 
H1780 with pDS1.1 carrying the Brucella abortus fur gene resulted in the generation of 
white colonies on iron-rich MacConkey agar (data not shown).  In contrast, 
transformation of H1780 with vector alone does not complement the fur mutation as 
evidenced by the continued production of β-galactosidase resulting in red colonies on the 
right-hand side of the plate despite the presence of a high concentration of iron (See 
Fig.2-1).  These data clearly indicate that the B. quintana Fur protein is a functional ferric 
uptake regulator that is able to recognize and bind the E. coli Fur box consensus 
sequence.  
 
     Synthesis of Fur in E. coli and B. quintana.  Initial attempts to identify the Fur 
protein utilized polyclonal antisera generated against E. coli Fur.  Western blots probed 
with this antisera showed reactivity with both uninduced and induced His6-tagged B. 
quintana Fur protein expressed in JM109 (Figure 2-2A lanes 1 and 2, respectively, p. 38).  
In contrast, although an ~ 50 kDa protein cross-reacts with the anti-E. coli Fur antisera, 
there is an absence of reactivity with any protein in the appropriate molecular weight 
range in the B. quintana cell lysate (Fig. 2-2A, lane 3).  In an effort to provide a more 
specific and accurate tool for the detection of B. quintana Fur, we generated anti-B. 
quintana Fur antisera using purified recombinant his6-tagged Fur.  Immunoblot analyses 
indicate strong reactivity to the recombinant B. quintana Fur protein when induced in E. 
coli (Fig. 2-2B, lane 2), but no reactivity with any protein in the B. quintana cell lysate 
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(Fig. 2-2B, lane 3).  Notably, anti-B. quintana Fur antisera also reacts with recombinant 
Brucella abortus Fur protein expressed in E. coli (data not shown, Table 2.3, p. 36).  
Together, these data suggest that the both antisera recognize conserved Fur antigens but 
that the protein is not synthesized in B. quintana under the growth conditions used for 
these experiments.  In an effort to increase expression of the Fur protein, B. quintana was 
treated with hydrogen peroxide for up to 2 hours and then assayed for Fur production by 
Western blot.  Again, these experiments failed to yield reactivity with the native Fur 
protein in B. quintana cell lysates (data not shown).     
 
     Mapping the B. quintana fur promoter by in vitro transcription/translation.  In 
the previous study examining Bartonella henselae Fur, a fusion construct consisting of 
the 204 base pairs (bp) fur promoter and the gene encoding green fluorescent protein 
(gfp) was used to transform B. quintana and B. henselae.  Promoter activity, as evidenced 
by the detection of GFP production by flow cytometry, was not detected despite growing 
the strains on a range of hemoglobin and iron concentrations (131).  These data, 
combined with the inability to detect native Fur from B. quintana cell lysates, led us to 
examine the potential transcriptional arrangement of this gene.  Genomic analyses 
indicate that Bartonella fur is separated from its upstream gene, secA, by only 17 bp or 
less in B. quintana, B. henselae, and B. bacilliformis (Fig. 2-3A, p. 39) (4).  Although it 
does not contain the fur gene, secA is transcribed as part of an operon in E. coli (127).  In 
an effort to locate the promoter region of fur, we generated a series of fur constructs 
containing portions of the upstream secA gene and directionally cloned them such that 
they were either in the same orientation or flipped with respect to the plasmid-encoded 
lac promoter.  Examination of the proteins synthesized from these constructs by in vitro 
transcription/translation (IVTT) indicates strong expression of the Fur protein when the 
fur gene is immediately preceded by the lac promoter (Fig. 2-3B lane 3, p. 39).  Faint 
expression of the Fur protein is also evident when the entire secA-fur gene fragment is 
cloned in the same orientation as the lac promoter (Fig. 2-3B lane 6). In contrast, Fur 
expression was not detectable when the fur gene was in the opposite orientation to the lac 
promoter (Fig. 2-3B lane 2) regardless of the inclusion of 1600bp of upstream secA 
sequence (Fig. 2-3B lane 4) or the entire secA gene (Fig. 2-3B lane 7).  Constructs 
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containing the entire secA gene produced SecA regardless of orientation (Fig. 2-3B lanes 
6 and 7).   
     IVTT data were corroborated by complementation and Western blot analysis.  
Specifically, constructs that produced detectable Fur in vitro also produced Fur in vivo as 
evidenced by reactivity with anti-Fur antisera and were able to complement the E. coli 
H1780.  All of the constructs containing fur in opposite orientation to the lac promoter 
failed to produce detectable Fur in vivo and failed to produce functional Fur in the E. coli 
fur strain (See Table 2.3).  In total, these data imply that although secA contains a 
functional promoter, B. quintana fur is not transcribed as part of an operon originating 
from secA.  In fact, B. quintana fur does not appear to possess a consensus promoter.   
 
     Synthesis and localization of B. quintana HbpA in E. coli.  Although a role for Fur 
in the transcriptional regulation of the hbp genes was not established, the ability of HbpA 
to function as a hemin receptor was still of interest.  In order to ensure proper trafficking 
of B. quintana HbpA in E. coli, Hbp's original signal sequence was replaced with the 
signal sequence from OmpT, a known outer membrane protein of E. coli.  Outer 
membrane localization of the recombinant HbpA fusion in E. coli was subsequently 
confirmed by sarkosyl fractionation and immunoblotting.  Briefly, selective solubilization 
of the bacterial cytoplasmic membrane in 0.5-2% (wt/vol) sarkosyl results in the isolation 
of outer membrane proteins (55).  The sarkosyl-insoluble protein profile of 
pWSKHbpA/EB53 resolved by SDS-PAGE is consistent with that presented in a 
previous study of E. coli using the same methodology (See Fig. 2-4A lane 6, p. 40) (48).  
A corresponding immunoblot shows the presence of the HbpA fusion in both uninduced 
and induced cell lysates from pWSKHbpA/EB53 but absent in EB53 containing only the 
vector (Fig. 2-4B, lanes 3, 4, and 2 respectively).  Moreover, the immunoblot indicates 
that although some HbpA is present in the sarkosyl-soluble fraction (lane 5), the majority 
of it resides in the sarkosyl-insoluble pellet (lane 6).  These results indicate that the 
majority of the B. quintana HbpA fusion protein is properly trafficked to the outer 
membrane in E. coli strain EB53.   
     Outer membrane localization was confirmed by proteinase K treatment of intact cells 
to examine the surface accessibility of HbpA in EB53.  Immunoblot analyses of cells 
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lysates from proteinase K-treated cells indicate a progressive decrease in the amount of 
HbpA that directly corresponds to treatment with successively higher concentrations of 
proteinase K (See Fig. 2-5B, lanes 2-5, p. 41).  Visible changes in HbpA were verified by 
densitometry (data not shown).  A corresponding silver-stained gel (Fig. 2-5A) served as 
a control for protein loading and showed a lack of non-specific protein degradation.  
Likewise, a protein slightly larger than HbpA that was cross-reactive with the anti-HbpA 
antisera served as an internal control and remained constant despite increasing 
concentrations of proteinase K (Fig. 2-5B, lanes 2-5).  These results provide strong 
evidence for appropriate trafficking of HbpA to the outer membrane of EB53.  
 
     Complementation of E. coli strain EB53.  In order to examine the ability of B. 
quintana HbpA to function as a hemin receptor, complementation analyses of the E. coli 
hemA aroB strain EB53 were undertaken.  EB53 is a K-12 derivative with a mutation 
preventing the generation of δ-aminolevulinic acid (ALA), a key intermediate in the 
porphyrin biosynthesis pathway.  In the absence of exogenously-supplied ALA, this 
strain is unable to exploit hemin as a porphyrin/hemin source due to the relative 
impermeability of the membrane to hemin and the absence of a native hemin receptor 
(153).  However, the severe growth defects resulting from this mutation can be corrected 
if a functional hemin receptor is provided.  We used this strain to test the hypothesis that 
B. quintana hbpA functions as a hemin receptor.  In short, overnight cultures of 
pWSKHbpA/EB53 and pWSK29/EB53 were incubated for ~2 hours in unsupplemented 
media to deplete intracellular porphyrin and ALA stores and were then used to inoculate 
TY media alone, or supplemented with ALA or hemin.  Growth curves were generated by 
measuring OD600 every four hours for 24 hours.  As expected, data indicate that both 
strains fail to grow in the absence of exogenously-supplied hemin or ALA (Fig. 2-6A, p. 
42).  When the hemA mutation was bypassed by the addition of 50 µM ALA, both strains 
produced normal growth curves (Fig. 2-6B, p. 43).  pWSK29/EB53 shows a slightly 
higher ‘leak’ rate than pWSKHbpA/EB53 when the strains are grown in media 
supplemented with 10 µg/ml hemin (Fig. 2-6C, p. 44).  This phenomenon is somewhat 
less pronounced when the hemin concentration is increased to 50 µg/ml (Fig. 2-6D, p. 
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45). Regardless, the pWSKHbpA/EB53 strain is not able to uptake exogenously-supplied 
hemin any faster than EB53 containing the vector alone at either hemin concentration.   
 
D.  DISCUSSION 
 
     These experiments were undertaken to characterize the mechanisms of hemin 
acquisition and its regulation in B. quintana.  The first aim of this study was to 
characterize the role of Fur in iron-responsive transcriptional regulation.  Unexpectedly, 
the data presented herein challenge the hypothesis that Fur is the dominant transcriptional 
repressor controlling heme and iron uptake in Bartonella.  Although the B. quintana fur 
gene encodes a functional Fur protein that recognizes the E. coli Fur box, there was no 
evidence of a promoter for the gene even when the search was extended to encompass the 
entire upstream secA gene and its promoter region.  It is tempting to speculate that the 
inability to identify an endogenous promoter by IVTT is due to the existence of a B. 
quintana-specific sigma factor required for transcription of fur.  However, consistent with 
the reported inability to detect a promoter in Bartonella using a B. henselae fur-gfp 
fusion, we also failed to detect any evidence of native Fur expression in B. quintana by 
immunoblotting (131).  A notable exception to the inability to detect Fur in Bartonella 
occurred when overexpression was forced by transformation of Bartonella with a 
construct containing the fur gene in the same orientation as a plasmid-encoded lac 
promoter (14).  This detail combined with the fact that the antisera reacted well with 
Brucella abortus Fur refute any possibility that the inability to detect Fur is due to weak 
or nonspecific antisera (data not shown).  In contrast, these data collectively suggest that 
Fur is not expressed in Bartonella under any of the conditions used in this study.   
      The absence of Fur expression in Bartonella implies the existence of an alternative 
iron-responsive regulator.  Consistently, several closely-related α-proteobacterial species 
have reported a diminished or nonexistent function for Fur in iron-mediated 
transcriptional control despite the almost universal presence of an intact fur gene (86).   
In several of these species, the role of Fur has been entrusted to one of two novel 
regulators.  The first of these is the rhizobial iron regulator, RirA, which resembles the 
iron-sulfur cluster regulator of E. coli and has primarily been characterized in Rhizobium 
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leguminosarum (171).  The other is the iron response regulator, Irr, which has been 
primarily characterized in Bradyrhizobium japonicum and is thought to respond directly 
to intracellular heme concentrations (195).  Genomic analyses revealed that genes 
encoding homologs to both of these proteins are present in B. quintana. Of note, the B. 
quintana Fur and Irr proteins share ~ 50% amino acid similarity across 91 residues (of 
138 possible residues) (Parrow and Minnick, unpublished observation).  Therefore, the 
focus of our investigation shifted to the role of Irr and RirA in the transcriptional 
regulation of the hbp genes.  Subsequent studies found that overexpression of either Irr or 
RirA in B. quintana resulted in the generation of a bloodstream-like transcriptional hbp 
profile, that is, increased transcription of hbpA, D, and E.  These data led to the 
identification of a conserved consensus sequence in the promoter region of the hbp genes, 
designated the H-box, which directly interacts with Irr.  In contrast, forced 
overexpression of Fur resulted in decreased transcription of only hbpC (14).  Based on 
previous data suggesting that HbpC may be important in colonization or survival in the 
louse gut and the probability that hemin and/or iron are released at toxic levels in this 
environment, it is possible that Fur is expressed in B. quintana in response to hemin 
concentrations that are toxic in vitro or to an alternative environmental trigger (13).  
     The second major aim of this study was to examine the ability of B. quintana HbpA to 
function as a hemin receptor.  Again, the data obtained from this investigation opposed 
the original hypothesis.  Despite replacing the native signal sequence of B. quintana 
HbpA with one certain to be recognized by E. coli followed by confirmation of 
appropriate outer membrane localization of recombinant HbpA in E. coli, this protein 
failed to complement the porphyrin biosynthesis defect in EB53.  While these data are in 
direct opposition to a previously-published report indicating that the B. henselae homolog 
Pap31 was able to function as a hemin receptor in EB53, it is important to note that the E. 
coli hemA strains are somewhat leaky when grown in the presence of hemin (199).  This 
characteristic increases the likelihood of obtaining a false-positive result, especially if 
growth is ascertained “by eye” rather than quantitatively.  The absence of any discernable 
TonB box in HbpA, as well as both structural and amino acid similarity to known hemin 
receptors, are consistent with our data (Parrow and Minnick, unpublished observation).  
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Genomic analyses indicate a more probable hemin receptor, HutA, which possesses these 
characteristics (discussed in Chapter 3).                      
     Even though HbpA is not a hemin receptor, the strength of the association between the 
Hbps and hemin is undeniable.  Furthermore, the entire Hbp family is transcriptionally 
responsive to fluctuations in hemin concentration (13).  Additionally, HbpA can be 
specifically retrieved from cell lysates using hemoglobin bound to agarose beads (data 
not shown).  Collectively, these observations suggest that this interaction is biologically 
relevant.  The possibility of a function parallel to that established for leghemoglobin in 
generating a microaerobic environment for the closely related nitrogen-fixing Rhizobium 
and Bradyrhizobium has been suggested (14).  However, an oxygen (O2)-labile 
nitrogenase is not readily apparent in the B. quintana genome (Parrow and Minnick, 
unpublished observation).  If the Hbps have a similar function in B. quintana, then the 
enzyme requiring protection from oxygen is novel or there is an alternative reason for 
excluding O2.   
     It is tempting to speculate that either the Hbps have an important but indirect role in 
hemin acquisition or that the hemin has a role in the adaptation of Bartonella to its 
radically different growth environments.  Previously suggested possibilities include the 
Hbps serving as a surface reservoir for hemin storage or as detoxifying entities via the 
intrinsic peroxidase activity of hemin (13).  An intriguing alternative to these potential 
functions is the possibility that surface heme serves as a sensor via its ability to bind 
biologically relevant molecules such as carbon monoxide (CO), nitric oxide (NO), and 
oxygen (O2).  A similar function for heme has been reported in mammalian cells, 
whereby heme binds to and blocks calcium-activated potassium channels but heme bound 
to CO releases the channel resulting in its activation (84).  Under such a model, the Hbps 
would function to transport an unknown molecule across the outer membrane, which 
their porin-like structure would facilitate, and heme would serve as a “gatekeeper”.  The 
opening and closing of the gate would in turn be dictated by the presence of a messenger 
molecule.  As a starting point for the investigation of this hypothesis, the 
spectrophotometric profile of the an Hbp-hemin solution could be compared with the 
profile generated by the same solution following addition of CO (84).   
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     In summary, the data presented herein indicate that HbpA is not able to transport 
hemin across the outer membrane when expressed in E. coli.  Likewise, our data indicate 
that Fur is not a dominant iron-responsive transcriptional repressor because it does not 
appear to be expressed under the conditions used in this study.  These data are significant 
primarily because they indicate the existence of alternative hemin acquisition systems 
(discussed in Chapter 3) and transcriptional regulators (14).  Furthermore, they indicate a 
more subtle role for the Hbps in heme acquisition.  Despite the inherent difficulties in 
untangling the interaction of the Hbps with hemin, due to the fact that it is absolutely 
required for in vitro growth of Bartonella, further studies of this unique family of 
proteins are warranted.  Elucidation of their function is expected to result in improved 
appreciation of Bartonella pathogenesis and host adaptation.  Furthermore, the 
identification of HbpE as one of the predominant proteins recognized by the human 
immune system underscores the importance of these proteins in vivo and may be 
exploited as a potential therapeutic target (23).                
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Table 2.1. Bacterial strains and plasmids used in this study 
 
Strain or plasmid Relevant Characteristic(s) Source/Reference
Bartonella quintana
     OK90-268 Human isolate CDC
     LS200 OK90-268 cured of pEST 122
E. coli
     DH5α Host strain for cloning Gibco-BRL
     JM109 Host strain for expression Promega
     H1780 MC4100 but fur:: λ placMu53 72
     EB53 hemA aroB rpoB 152
Plasmid
     pCR2.1 TOPO TA cloning vector Invitrogen
     BqFur TOPO pCR2.1 TOPO with B. quintana fur  insert 130
     pNP10 pCR2.1 TOPO with B. quintana fur and flanking insert; This study
same orientation as Plac
     pNP20 As FurB/TOPO but opposite orientation to Plac This study
     pNP30 pCR2.1TOPO with 1600 bp of B. quintana secA  and fur ; This study
opposite orientation as Plac
     pQE30 Expression vector Qiagen
     pNP70 pQE30 with B. quintana fur  insert This study
     pUC 9 Cloning vector Kovach, M.E.
     pDS1.1 pUC 9 with Brucella abortus fur  insert Kovach, M.E.
     pWSK29 Low-copy expression vector 183
     pWSKHbpA pWSK29 with B. quintana hbpA(ompTSS) This study
     XL-TOPO TA cloning vector for long PCR products Invitrogen
     pNP40 XL-TOPO with 3336 bp B. quintana secAfur  insert; This study
same orientation as Plac
     pNP50 As SecAFur 3/ XL-TOPO but opposite orientation to Plac This study
     pBBR1MCS Broad host range vector Kovach, M.E.
     pNP60 FurB but pBBR1MCS; same orientation as Plac This study  
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Table 2.2 Primers used in this study 
Primers
SacI OmpTSS For AGAGCTCTGCAAGCCATTGCGAGGCCT
OmpTSS Rev AGCAATAACATCAGCAGCAAAAGAGCTGATCGCAATAGGGGTTGTCAG
HbpA For GTCCTGACAACCCCTATTGCGATCAGCTCTTTTGCTGCTGATGTTATTGC
HbpA ApaI Rev GTGGGCCCACAATCACAAAAATAGAGG
pbbrfur For CACCTAGGATGAATAAAAAACGAAATTATGAG
pbbrfur Rev ACGGCGCGCCGTTACTAGTGGATCCGAGCTC
BqfullFur ORF For GTAATGAGCGTTGCCCTTGTGG
BqfullFur ORF Rev GTATAAAATTCAATTCGCATGAGG
SecA3 For ATAGGAAACTGTCTGGCATGACGG
SecA full ORF For GCGCACCAACAAGTATAATGATACC
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Table 2.3.  Summary of Fur constructs and experimental results for each.  
Abbreviations: C’= complementation data; Ab = Anti-Fur antibody recognition; ND = 
not determined. 
Strain Consists of IVTT C' Ab 
pNP60 B. quintana fur  and flanking sequences in pBBR1MCS ND yes yes
pDS1.1 Brucella abortus fur ND yes yes
pNP10 pNP60 but pCR2.1TOPO; same orientation as Plac yes yes yes
pNP20 pNP10 but opposite orientation as Plac no no no
pNP30 1600bp of B. quintana secA and fur; no no no
in opposite orientation to Plac
pNP40 3336 bp B. quintana secA-fur insert; faint partial faintly
same orientation as Plac
pNP50 pNP40 but opposite orientation to Plac no no no
BQ Fur 2/ Topo B. quintana fur insert in pCR2.1TOPO yes partial yes
pNP70 B. quintana fur  insert in pQE30 ND no yes  
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A)                                                       B) 
 
 
Figure 2-1.  Complementation of E. coli fur mutant H1780 with B. quintana fur.  
Overnight growth of H1780 containing A) pNP60 and B) pBBR1MCS on iron-rich 
MacConkey agar. B-galactosidase activity is evident by the production of red colonies in 
B), while its repression is indicated by the production of whitish-yellow colonies in A).   
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 A)                                                                                 B) 
 
 
Figure 2-2.  Analysis of Fur expression by immunoblotting.  Western blot of cell 
lysates from uninduced JM109/pNP70 (lane 1), induced JM109/pNP70 (lane 2), and B. 
quintana strain LS200 (lane 3) probed with A) anti-Fur antiserum generated with E .coli 
Fur or B) anti-Fur antiserum generated with B. quintana Fur.  The recombinant His6-
tagged Fur protein is evident in the induced samples when blots are probed with either 
antiserum.  Although cross reactive proteins are present when probed with the E. coli 
antisera, Fur is not apparent in the B. quintana lysate in either blot.      
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A) 
 
B) 
 
 
Figure 2-3.  Absence of an endogenous fur promoter by in vitro transcription/ 
translation. A)  Schematic showing the genomic arrangement of the secA and fur genes 
in B. quintana and the relative sizes of the various constructs used in IVTT.  B) IVTT 
analysis of constructs containing B. quintana fur containing portions of the upstream 
secA gene in the same or opposite orientation to the plasmid-encoded lac promoter.  
Lanes: 1, pCR2.1 TOPO; 2, pNP20; 3, pNP10; 4, pNP30; 5, XL-TOPO; 6, pNP40; 7, 
pNP50.  A Fur product is evident in lane 3 and faintly visible in lane 6.  Molecular mass 
standards are given on the left in kilodaltons.     
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A)                                                                     B) 
 
 
Figure 2-4.  Outer membrane localization of HbpA in E. coli strain EB53 by 
sarkosyl fractionation.  Lanes: 1, Molecular mass standards; 2, pWSK29/EB53; 3, 
pWSKHbpA/EB53 (uninduced); 4, pWSKHbpA/EB53 (induced); 5, pWSKHbpA/EB53 
sarkosyl-soluble fraction; 6, pWSKHbpA sarkosyl-insoluble fraction.  A)  Coomassie 
blue stained SDS-PAGE gel.  B)  Corresponding immunoblot developed with anti-HbpA 
showing HbpA is present in uninduced and induced cell lysates, as well as both sarkosyl 
fractions.  The majority of the HbpA is in the outer membrane.  Molecular mass 
standards are indicated on the left in kilodaltons. 
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A)                                                                B) 
 
Figure 2-5.  Surface accessibility of HbpA in E. coli strain EB53 by proteinase K 
digestion.  A)  Silver stained SDS-PAGE gel of proteinase K-treated pWSKHbpA/EB53. 
Lanes: 1, 0µg/ml PK; 2, 100µg/ml PK; 3, 500µg/ml PK; 4, 1000µg/ml PK; 5, 1500µg/ml 
PK.  B)  Corresponding immunoblot probed with anti-HbpA indicates surface 
accessibility as evidenced by dose-dependent proteinase K sensitivity.    
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A) 
 
 
 
Figure 2-6.  Complementation of E. coli hemA strain with B. quintana hbpA.  24 hour 
growth curves of E. coli EB53 containing vector alone (pWSK29) or pWSKHbpA 
inoculated into TY media: A) containing neither ALA nor hemin B) supplemented with 
50µM ALA C) supplemented with 10µg/ml hemin  or D) supplemented with 50µg/ml 
hemin.   
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 48 
CHAPTER THREE 
Function, Regulation, and Transcriptional Organization of the Hemin Utilization 
Locus of Bartonella quintana 
Nermi L. Parrow, Jasmin Abbott, Amanda R. Lockwood, James M. Battisti, and Michael 
F. Minnick.  2009. Infect. Immun. 77(1): 307-316 
 
 
A.  ABSTRACT 
 
Bartonella quintana is a Gram-negative agent of trench fever, chronic bacteremia, 
endocarditis, and bacillary angiomatosis in humans.  B. quintana has the highest known 
hemin requirement among bacteria, but the mechanisms of hemin acquisition are poorly 
defined.  Genomic analyses revealed a potential locus dedicated to hemin utilization (hut) 
encoding a putative hemin receptor, HutA, a TonB-like energy transducer, an ABC 
transport system comprised of three proteins, HutB, HutC, and HmuV, and a hemin 
degradation/storage enzyme, HemS.  Complementation analyses with E. coli hemA show 
that HutA functions as a hemin receptor and in E. coli hemA tonB indicate that HutA is 
TonB-dependent.  Quantitative reverse transcription polymerase chain reaction (qRT-
PCR) analyses show that hut locus transcription is subject to hemin-responsive 
regulation, which is primarily mediated by the iron response regulator (Irr).  Irr functions 
as a transcriptional repressor of the hut locus at all hemin concentrations tested.  
Overexpression of ferric uptake regulator (fur) represses transcription of tonB in the 
presence of excess hemin, whereas overexpression of the rhizobial iron regulator (rirA) 
has no effect on hut locus transcription.  RT-PCR analyses show that hutA and tonB are 
divergently transcribed, and remaining hut genes are expressed as a polycistronic mRNA.  
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Examination of the promoter regions of hutA/tonB and hemS indicates homology to 
consensus sequence promoters and encompasses an H-box element previously shown to 
interact with B. quintana Irr.   
 
B.  INTRODUCTION 
 
     Bartonella quintana, the Gram-negative bacterial agent of epidemic trench fever 
during World Wars I and II, is one of several Bartonella species of current medical 
relevance (27).  B. quintana is transmitted to humans via the human body louse 
(Pediculus humanus corporis) and is re-emerging in large metropolitan areas amongst 
destitute individuals as ‘urban trench fever’.  Risk factors for urban trench fever include 
alcoholism, homelessness, and exposure to body lice (33).  Unlike classical trench fever, 
a self-limiting flu-like disease, the re-emerging disease is associated with chronic 
bacteremia and endocarditis regardless of immune status (33).  B. quintana infection can 
also result in bacillary angiomatosis (BA); which is the development of proliferative 
vascularized lesions of the skin (43).  Although BA primarily affects patients infected 
with human immunodeficiency virus (HIV) or other immunodeficiencies, a limited 
number of cases have been reported in immunocompetent individuals (46).   
     HIV infects approximately 0.47% of the general U.S. adult population and there are an 
estimated 800,000 homeless people in the U.S. on any given day (26,38).  Some studies 
suggest that HIV prevalence is up to five times higher in homeless populations than in the 
general population (1).  Despite the relatively large population at risk for B. quintana 
infection, trench fever is recognized as a “neglected infection of poverty” (19).  
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Accordingly, insufficient data exist for a general estimate of prevalence in the U. S. and 
very little is known about the pathogenesis of this bacterium.   
     Utilization of host heme-containing proteins as a source of iron is a common strategy 
for bacterial pathogens (16).  In addition to using these heme or hemin (the Fe
3+
 oxidation 
product of heme) sources, Bartonella species are unique in their ability to parasitize 
human erythrocytes (27,37).  In the absence of erythrocyte lysates or hemoglobin, in vitro 
growth of B. quintana requires media supplemented with the highest known 
concentrations of hemin among bacterial species (31).  Free heme is toxic in humans due 
to its lipophilic nature and ability to participate in the generation of reactive oxygen 
species via Fenton chemistry.  Therefore, it is either rapidly catabolized by a heme 
oxygenase system or neutralized by one of several host heme-binding proteins, 
maintaining a very low concentration (22).  However, complexed heme, primarily 
hemoglobin, is abundant (16).  Acquisition of heme in the limiting environment of the 
human host is pivotal to the survival and pathogenesis of B. quintana.  In contrast to the 
human host, free heme is thought to exceed toxic levels in the gut of blood-sucking 
arthropods during the initial digestion of a blood meal (34).   The ability of B. quintana to 
withstand the heme-limiting environment of the human host and the heme-replete gut of 
the body louse suggests that its heme acquisition systems are tightly regulated. 
     Little is known about molecular mechanisms or regulation of heme acquisition by 
Bartonella.  Previous studies by our lab focused on the hemin-binding proteins (HbpA-
E), a five-member family of outer membrane porin-like proteins (28).  In addition to 
binding hemin, Hbps are transcriptionally regulated in response to variations in ambient 
temperature, oxygen levels, and hemin concentration (5).  This regulation is mediated in 
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part by Irr (iron response regulator), a member of the ferric uptake regulator (Fur) 
superfamily first described in Bradyrhizobium japonicum, that responds directly to hemin 
(17).  Irr acts as either a transcriptional activator or repressor by binding the iron control 
element (ICE) of B. japonicum, and the effect of Irr on target genes is believed to be a 
consequence of ICE’s location relative to the transcriptional start site (39).  In B. 
quintana, Irr operates by binding a unique DNA motif found in the promoter region of all 
hbp genes, termed “H-box” (6).  B. quintana has at least two additional iron- and/or 
hemin-responsive regulators, namely Fur and RirA (rhizobial iron regulator A) (2).  In γ-
proteobacteria, Fur functions as a transcriptional regulator of iron and hemin uptake 
systems with activation dependent on intracellular iron concentrations (18).  In contrast, 
Fur has been shown to play a diminished or nonexistent role in α-proteobacteria (20).  fur 
overexpression in B. quintana resulted in decreased hbpC transcription but had no effect 
on other hbp genes (6).  RirA has primarily been studied in Rhizobium leguminosarum 
and is homologous to the iron-sulfur cluster regulator (IscR) of E. coli (48).  
Overexpression of rirA in B. quintana resulted in increased expression of hbpA, hbpD, 
and hbpE (6).   
     Hbps lack amino acid sequence similarity and predicted structural similarity to known 
bacterial hemin receptors, despite their ability to bind hemin and regulation by hemin-
responsive transcription factors (10).  Therefore, we hypothesized that an alternate hemin 
uptake and utilization locus was present in B. quintana and identified a candidate through 
analysis of the available genome (2).  The current study was undertaken to characterize 
the function, regulation, and transcriptional organization of this locus. 
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C.  MATERIALS AND METHODS 
      
     Bacterial strains and growth conditions.  E. coli was routinely grown overnight at 
37
o
C in Luria-Bertani (LB) or tryptone-yeast extract (TY) media with standard antibiotic 
concentrations when required.  For induction of gene expression, IPTG (isopropyl-β-D-
thiogalactopyranoside) was added to mid-log cultures at a final concentration of 2mM 
and cultures were grown for an additional 4-5 h.   For growth of E. coli hemA strains 
EB53 and IR754, media were supplemented with 25µM δ-aminolevulinic acid  (ALA) 
(Research Products International , Prospect, IL) (12).  B. quintana strains were grown on 
chocolate agar or on Brucella agar (BA) (Becton Dickinson, Sparks, MD) supplemented 
hemin chloride (CalBiochem, San Diego, CA) at 37
o
C in 5% CO2 and 100% relative 
humidity.  10mg/ml hemin chloride was dissolved in 0.2M NaOH and filter sterilized for 
a stock solution.  In order to maintain pBBR1MCS and derivatives in B. quintana, 
medium was supplemented with 1µg/ml chloramphenicol.  B. quintana plates were 
harvested at mid-log phase [3-5d post-inoculation (6)] and age-matched for individual 
experiments.  Strains used in this study are summarized in Table 3.1 (p. 65).   
 
     In silico analyses.  Genomic sequences for B. quintana strain Toulouse were accessed 
at the RhizoDB website (http://xbase.bham.ac.uk/rhizodb/) (11) or the National Center for 
Biotechnology Information website (http://www.ncbi.nlm.nih.gov).  BLAST was 
employed for all database searches (3) and ClustalW version 2.0 (23) was used for 
multiple amino acid sequence alignments.  The Protein Homology / Analogy Recognition 
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Engine (Phyre) program (9) was used to predict three-dimensional protein structures 
(http://www.sbg.bio.ic.ac.uk/phyre/).   
 
     Preparation and manipulation of nucleic acids.  B. quintana genomic DNA was 
purified with a DNeasy Blood and Tissue kit (Qiagen, Valencia, CA).  Plasmids were 
purified with a QIAprep Spin Miniprep kit (Qiagen), Perfectprep Plasmid Mini kit 
(Eppendorf, Hamburg, Germany), or Wizard Plus Midiprep DNA Purification System 
(Promega, Madison, WI).  Routine procedures were employed for PCR amplification, 
ligation, cloning and restriction endonuclease digestion (4).  PCR and sequencing primers 
were synthesized by Operon Biotechnologies (Huntsville, AL).     
     Total RNA was isolated from B. quintana immediately upon harvest with a RiboRure-
Bacteria Kit (Ambion, Austin, TX) per protocol except cell lysis was done with an FP120 
Fast Prep bead homogenizer (45 sec at top speed) using Zirconia beads supplied 
(Qbiogene, Carlsbad, CA).  DNase treatment was accomplished with a Turbo DNA-free 
kit (Ambion).  Nucleic acids were quantified using a Spectronic Genesys 2 (Milton Roy, 
Rochester, NY) or a NanoDrop ND-1000 (Thermo Fisher Scientific, Waltham, MA) 
spectrophotometer.  Based on published sequence (2), primers for qRT-PCR were 
synthesized by Integrated DNA Technologies (Coralville, IA) and are listed in 
Supplementary Table 3.1 (p. 65).   
 
     Complementation assays.  The ability of E. coli hemA strains EB53 or IR754 
(containing pNP1 or vector alone) to use hemin was examined as previously described 
with modifications (47).  Briefly, overnight cultures were centrifuged at 3900 x g for 5 
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min at 4
o
C and pellets were resuspended in 5ml TY without ALA.  Cultures were 
incubated ~2 h at 37
o
C with shaking to deplete intracellular ALA and hemin and then 
used to inoculate 8ml cultures of TY alone or supplemented with either ALA (50µM) or 
hemin chloride (10µg/ml or 50µg/ml) to an initial optical density of 0.02 at 600 nm 
(OD600).  Cultures were incubated at 37
o
C with agitation and OD600 was measured every 
4 h for 24 h.   
 
     Generation of anti-HutA antisera.  A 6xHis-tagged mature B. quintana HutA 
protein was generated and purified under denaturing conditions using the QIAexpress kit 
(Qiagen).  Purified protein fractions were separated by sodium dodecyl sulfate-
polyacrylamide gel electrophoresis (SDS-PAGE) and 12.5% (wt/vol) acrylamide gels (4).  
Gels were rinsed three times for 5 min in deionized water and then stained with 0.05% 
(wt/vol) Coomassie blue in deionized water for ~30 min.  Following destaining in water, 
the purified HutA band was excised and used to generate rabbit anti-HutA antiserum as 
previously described (42). 
 
     Sarkosyl fractionation and immunoblotting.  Proteins were quantified by a 
bicinchoninic acid protein kit (Pierce, Rockford, IL).  Sarkosyl fractionation was 
performed essentially as previously described (52).  Briefly, overnight cultures of E. coli 
were harvested, washed in phosphate-buffered saline (pH 7.4), and resuspended in sterile 
distilled H2O.  Cell lysis was done with a Fastprep bead homogenizer as above.  Cells 
were incubated for 30 min in 2% (vol/vol) N-lauroyl sarcosinate (Sigma, St. Louis, MO) 
at room temperature and then centrifuged for 1 h at 100,000 x g at 4
o
C in a SW60Ti rotor 
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(Beckman Coulter, Fullerton, CA).  The sarkosyl-insoluble pellet was resuspended in 
0.2mM phenylmethylsulfonyl fluoride (PMSF) in deionized water (Sigma).  Both the 
resuspended pellet and sarkosyl-soluble supernatant fraction were stored at -20
o
C until 
needed. Samples were resolved by SDS-PAGE and transferred to supported 
nitrocellulose (GE Water & Process Technologies, Trevose, PA) for immunoblotting 
(49).  Resulting blots were probed overnight with rabbit anti-HutA antiserum and 
developed with horseradish peroxidase-conjugated goat anti-rabbit antibodies (Sigma), 4-
chloronaphthol, and hydrogen peroxide, as previously described (42).     
 
     qRT-PCR and RT-PCR.  Relative differences in hut locus expression were 
quantified in B. quintana grown on BA supplemented with low (0.05mM) or high 
(2.5mM) hemin relative to an optimal hemin concentration (0.15mM) or for JK31 
overexpressing fur, irr, or rirA relative to JK31 with pBBR1MCS vector alone (6).  For 
each condition, 500ng RNA was reverse transcribed per manufacturer’s instructions with 
iScript cDNA Synthesis Kit (Bio-Rad, Hercules, CA). 0.67 ng template cDNA and 
500nM of each primer were used per 25µl reaction with iQ SYBR Green Supermix (Bio-
Rad) as recommended.  qRT-PCR reactions were incubated for 5 min at 95
o
C, then 40 
cycles at 95
o
C for 30 sec followed by 55
o
C for 30 sec.  Data were obtained with a MyIQ 
Real-Time PCR detection system and Optical System software version 1.0 (Bio-Rad).  
Mean values from each triplicate reaction were used to determine individual fold 
differences in gene expression by the 2
-∆∆Ct
 method using 16S rRNA as the internal 
control (24).     
 56 
     Transcriptional organization of the hut locus genes was examined by reverse 
transcribing the hmuV transcript and using it for PCR amplification of individual hut 
genes as previously described (29).  Briefly, 500-1100ng DNase-treated RNA from JK31 
grown on BA containing 0.05mM hemin was reverse transcribed using SuperScript III 
First Strand Synthesis for RT-PCR (Invitrogen) per protocol.  Resulting cDNA was used 
as a PCR template with primer sets for hemS, hutA, hutB, hutC and hmuV.  A reaction 
lacking reverse transcriptase was used as a PCR template to control for contaminating 
DNA.   
 
     Transcriptional start site (TSS) mapping.  RNA was isolated from B. quintana  
grown on BA supplemented with 0.05 or 0.15mM hemin and used for TSS mapping of 
tonB, hutA, and hemS with a 5’ RACE system for Rapid Amplification of cDNA Ends, 
version 2.0 (Invitrogen, Carlsbad, CA).  Briefly, RNA was reverse transcribed with 
Superscript II and the resulting cDNA was RNase treated.  Following purification of 
cDNA with a QIAquick PCR purification kit (Qiagen), a 3’ dC tail was added, and tailed 
cDNA was PCR amplified with the Abridged Anchor Primer (AAP) supplied in the 
5’RACE kit and a nested, gene-specific primer.  PCR products were cloned into pCR2.1-
TOPO and used to transform E. coli TOP10F’ per TOPO TA Cloning (Invitrogen) 
protocol.  Plasmids were screened for appropriately sized inserts and sequenced.  
 
      DNA sequencing.  Sequence data were obtained with an automated DNA sequencer 
(AB3130x1 Genetic Analyzer) and a BigDye Terminator Cycle Sequencing Ready 
 57 
Reaction kit 3.1 (ABI, Foster City, CA).  Sequence data were analyzed with ChromasPro 
1.13 (http://www.technelysium.com.au/ChromasPro.html).     
 
     Statistical analyses.  Three independent determinations were used to calculate the 
mean and standard deviations for all numerical data.  Statistical significance was 
determined using the Student’s t test with P values < 0.05 considered significant.   
 
D.  RESULTS 
In silico analyses of B. quintana hut locus.  The hut locus consists of six genes 
encoding a potential receptor, HutA, an ABC transport system, HutBC and HmuV, a 
TonB orthologue, and a hemin storage/degradation enzyme, HemS (Fig. 3-1A, p. 66).  
The gene arrangement suggested the possibility for divergent transcription of tonB and 
hutA (8), while hemS, hutBC and hmuV appeared polycistronic due to close linkage.  
BLAST analyses indicated that orthologues exist for each member of the hut locus in 
other α-proteobacteria (Fig. 3-1A).  Of note, B. quintana TonB lacks an N-terminal 
domain that facilitates ExbB-ExbD (cytosolic membrane proteins used in energy 
transduction) contact and cytoplasmic anchorage in E. coli (35).  Similarly, the predicted 
TonB box of B. quintana HutA shares only ~50% conservation with the consensus 
sequence of TonB-dependent proteins (data not shown) (30).  ClustalW alignment of 
HutA with hemin/hemoglobin receptors of other pathogenic bacteria shows conservation 
of characteristic FRAP and NPNL domains (10) (Fig. 3-1B, p. 67).   A conserved 
histidine (HIS 461) essential for hemin utilization by Yersinia enterocolitica HemR has 
been replaced by a tyrosine (TYR 505) in B. quintana HutA (10) (Fig. 3-1B).  This 
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substitution is also seen in BhuR, the Bordetella avium heme/hemoprotein receptor (30).  
Like BhuR, HutA shares more homology with the “heme scavenger” subclass of 
receptors than with the hemoglobin subclass (e.g., HmbR of Neisseria meningitides) (45).  
Three dimensional modeling of B. quintana HutA shows structural similarity to the ferric 
citrate receptor (FecA) of E. coli (14), where threading revealed the expected twenty-two 
antiparallel β-strands and 11 extracellular loops characteristic of TonB-dependent 
receptors (data not shown) (13).  TYR 505 was centrally positioned in one of the 
extracellular loops of the protein, as were four additional tyrosines (i.e., residues 278, 
451, 511, and 512) and histidine 389 (9).  In silico data strongly suggest the hut locus is a 
system dedicated to hemin acquisition and that HutA functions as the receptor.  
 
Complementation of E. coli hemA strains.  The outer membrane of E. coli K12 is 
impermeable to hemin, and growth defects from mutations in porphyrin biosynthesis 
genes cannot be overcome with hemin supplements (41).  E. coli hemA aroB strain EB53 
is a K12 derivative with a mutation in glutamyl-tRNA reductase, required for 
biosynthesis of ALA and ultimately protoporphyrin IX (7).  Exogenously supplied ALA 
can restore growth of EB53, however, utilization of hemin requires a functional hemin 
receptor (44).  To test the hypothesis that B. quintana HutA functions as a hemin 
receptor, hutA was cloned into pWSK29 to produce pNP1 and used to transform EB53.  
When grown in the absence of ALA and hemin, EB53/pWSK29 and EB53/pNP1 
exhibited the characteristic “leaky” growth (maximum OD600 of ~ 0.185 in 24 h; data not 
shown) previously noted in these strains (41).  Normal growth curves were obtained for 
both EB53/pWSK29 and EB53/pNP1 when TY broth was supplemented with 0.05mM 
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ALA (data not shown).  However, when media were supplemented with 10µg/ml hemin, 
EB53/pNP1 grew to a significantly higher OD600 by 24 h (p<0.029) than EB53/pWSK29 
(Fig. 3-2A, p. 68).  This difference was more pronounced when strains were grown in 
media supplemented with 50µg/ml hemin (p<0.0002) (Fig. 3-2B).  Interestingly, rescue 
of the hemA mutation in E. coli by B. quintana HutA is not apparent until ~16 h post-
inoculation despite hemin/ALA starvation.  Regardless, these data indicate that B. 
quintana HutA functions as a hemin receptor, and its expression in EB53 is sufficient to 
allow utilization of hemin as a porphyrin source.           
     In order to examine HutA’s potential dependence on TonB for energization, pNP1 was 
also used to transform E. coli strain IR754 (47).  As observed in the EB53 strains, both 
IR754/pWSK29 and IR754/pNP1 exhibited normal growth curves in TY media 
supplemented with 0.05mM ALA and neither strain surpassed the basal “leaky” growth 
level in media lacking both ALA and hemin (data not shown).  However, expression of B. 
quintana HutA could not restore growth of IR754 in media supplemented with either     
10µg/ml or 50µg/ml hemin (Figs. 3-2A and 3-2B, respectively) in direct contrast to 
EB53.  These data clearly indicate that HutA-mediated hemin uptake is dependent on E. 
coli TonB. 
 
Synthesis of HutA in B. quintana and E. coli.  We were able to identify native HutA in 
B. quintana and recombinant His-tagged HutA in E. coli strain JM109/pNP3 (data not 
shown), but were unable to detect HutA in E. coli strain EB53/pNP1 by Coomassie blue 
staining or Western blotting.  However, expression and induction of hutA mRNA in E. 
coli strain EB53/pNP1 were detectable by qRT-PCR.  As expected, cDNA from 
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EB53/pWSK29 gave results similar to those obtained from a no-template control (data 
not shown).  Recombinant HutA protein is undoubtedly localized to the outer membrane 
of EB53/pNP1 as deduced from its ability to rescue the hemA mutation and restore 
growth in the presence of hemin.  Failure to detect HutA in EB53/pNP1 is possibly due to 
a combination of low level expression and antiserum cross-reactivity.  A similar situation 
was reported for detection of the recombinant B. henselae orthologue (Pap31) in E. coli 
strain M15 until a monoclonal antibody was employed (52).  
 
Transcription of hut locus genes is hemin-responsive.  hut locus genes were expected 
to be tightly regulated in response to available hemin.  To investigate this hypothesis, 
RNA was isolated from B. quintana grown on media supplemented with low (0.05mΜ), 
optimal (0.15mM), and high (2.5mM) concentrations of hemin and used to examine 
differences in hut levels by quantitative reverse transcriptase-polymerase chain reaction 
(qRT-PCR).  Data show that expression of hut locus genes from JK31 grown on BA-
0.05mM hemin is only ~1.5-fold higher than that obtained from JK31 grown on BA-
0.15mM hemin, suggesting that this range of hemin concentrations does not substantially 
alter expression of the hut locus.  The most pronounced change was observed when 
transcript levels from JK31 grown on BA-2.5mM hemin were compared to those from 
JK31 grown on BA-0.15mM, where results show an ~2.2-fold decrease in transcription 
of hut locus genes in response to excess hemin (Fig. 3-3, p. 69).  Furthermore, the hut 
locus genes are coordinately regulated as evidenced by the fact that fold differences for 
each hut locus gene are repressed to approximately the same magnitude.  These results 
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show that hut locus genes are transcriptionally down-regulated in response to excess 
hemin.   
 
Hemin-responsive control is mediated by B. quintana Irr.  To elucidate regulation of 
hut locus genes, JK31 strains that overexpress one of three iron/hemin-responsive 
regulator genes were used for qRT-PCR experiments to investigate the effects on 
transcription.  RNA was isolated from overexpression and vector-only strains grown in 
parallel on BA-0.05mM hemin, BA-0.15mM hemin, and BA-2.5mM hemin to control for 
cofactor availability.  Average fold differences between JK31+pBBR-RIRA and 
JK31+pBBR indicate a 7 to 16-fold increase in rirA transcription but less than a 1.8-fold 
increase in transcription of any hut locus gene under optimal or hemin-limiting growth 
conditions.  Likewise, overexpression of rirA results in less than a 1.8-fold decrease in 
transcription of any hut locus gene when RNA is isolated from strains grown in the 
presence of excess hemin (Fig. 3-4A, p. 70).  These data suggest that rirA overexpression 
does not appreciably affect transcription of hut locus genes regardless of ambient hemin 
concentration.  
     Similar results were obtained when hut locus transcript levels were compared in 
JK31+pBBR-FUR relative to JK31+pBBR after growth on BA-0.05mM hemin.  These 
conditions resulted in less than a 1.7-fold increase in any hut locus gene, while fur 
overexpression was evident by a 4.4-fold increase (Fig. 3-4B, p. 71).  On BA-0.15mM 
hemin, fur transcription was increased ~8-fold in JK31+pBBR-FUR relative to 
JK31+pBBR, hemS levels were almost identical, and the remainder of the hut locus genes 
showed a minor decrease in transcription.  fur overexpression results in a 2.5-fold 
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increase in fur and a 4-fold decrease in tonB, when comparing hut locus expression from 
strains grown in the presence of excess hemin,.  The remainder of the hut locus shows 
only a minor decrease in expression as seen in strains grown with optimal hemin 
concentrations.  These data suggest that fur overexpression in the presence of excess 
hemin exerts a repressive effect on tonB that is not imposed on other members of the hut 
locus.       
     irr overexpression results in decreased transcription of the entire hut locus (Fig. 3-4C, 
p. 72).  Average fold differences in transcription of hut locus genes from JK31+pBBR-
IRR relative to JK31+pBBR resulted in a 7 to 12-fold increase in irr mRNA and an ~2.5 
fold decrease in transcription of all hut genes regardless of hemin concentration.  
Interestingly, the decrease in transcription during irr overexpression is similar in 
magnitude to the decrease in hut locus expression in the presence of excess hemin (Fig. 
3-3, p. 69).  These data suggest that hemin-responsive regulation of hut genes is 
mediated, at least in part, by Irr.   
 
Transcriptional organization of the hut locus.  Genomic arrangement of the hut locus 
suggested that hutA and tonB might be divergently transcribed, while hemS, hutBC, and 
hmuV could be polycistronic (Fig. 3-1A, p. 66).  To test these hypotheses, RNA from 
JK31 was reverse transcribed with a hmuV primer.  PCR analyses were performed on the 
resulting cDNA using primers specific to each member of the hut locus (except tonB) and 
a separate PCR reaction using genomic DNA template was used as a positive control for 
each gene.  Data indicate that hemS, hutB, hutC, and hmuV are all present in the hmuV 
transcript as evidenced by the PCR amplicons generated with primers specific to each of 
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these genes from the hmuV cDNA.  In contrast, no hutA amplicon is generated from the 
cDNA (Fig. 3-5, p. 73). Furthermore, no PCR amplicons were generated from the 
reactions using the sample that was not reverse transcribed, which confirms the absence 
of contaminating DNA.  These data show that hemS, hutB, hutC, and hmuV are co-
transcribed as part of a polycistronic transcript from the hemS promoter, while hutA is 
transcribed as a separate mRNA.                      
 
TSS mapping and identification of “H-box” elements.  To further elucidate regulation 
of the hut locus, TSS’s were mapped for tonB, hutA, and hemS by 5’ RACE.  The hutA 
TSS was found 121 bp upstream of its start codon, and the tonB TSS was mapped 40 bp 
upstream of its start codon.  Putative -10 and -35 sites were identified in the 78-bp 
divergent promoter region (Fig. 3-6A, p. 74).  Examination of the divergent promoter 
region between tonB and hutA showed ~69% identity with a 40-bp consensus sequence, 
previously identified in Bartonella hbp promoter regions (6).  The H-box completely 
encompasses the -10 and -35 sites of hutA and is located 1 bp before the potential -35 site 
of tonB.  In contrast, no obvious similarity to the Fur-binding motifs of E. coli or B. 
japonicum Fur proteins was found upstream of tonB (15).   
     The hemS TSS was mapped 70 bp upstream of the start codon and potential -10 and -
35 sites were identified relative to the TSS (Fig. 3-6B, p. 75).  The hemS promoter region 
also contains a site with ~57% identity to the H-box consensus sequence.  This region 
overlaps the predicted -35 site of hemS but does not extend to the -10 site.  Identification 
of motifs similar to the H-box and surrounding consensus sequence in the promoter 
region of hutA/tonB and hemS is consistent with qRT-PCR data showing repressive 
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effects of irr overexpression on hut locus expression (Fig. 3-4C, p. 72).  Together, these 
results suggest Irr represses transcription of hut locus genes by binding at or near RNA 
polymerase recognition sites.             
 
E.  DISCUSSION 
 
     Genomic analyses of the B. quintana genome show multiple systems possibly 
involved in hemin and/or iron acquisition.  One of these, the hut locus, appeared to be the 
most likely and complete candidate for a hemin uptake system.  Based on multiple lines 
of in silico evidence, including amino acid similarity, domain conservation, and structural 
similarity, we hypothesized that HutA was functioning as a hemin receptor (Fig. 3-1, p. 
66).   
     We tested the hypothesis by functional expression of B. quintana hutA in E. coli hemA 
strain EB53 (12, 41).  Expression of hutA trans-complemented EB53 was tested in the 
presence of hemin at two concentrations (Fig. 3-2, p. 68).  The E. coli hemA strains have 
a leaky phenotype which accounts for the low level increase in optical density over time 
(41).  The results required an ~12-16 h lag before a difference in growth rates was 
discernible between complemented and control strains.  This observation may be due to 
limited homology between TonB and TonB boxes of B. quintana and E. coli (30).  
Nevertheless, sufficient homology in TonB allowed B. quintana HutA to function as a 
hemin receptor in EB53, whereas HutA could not complement an otherwise isogenic E. 
coli strain (IR754) where both tonB and hemA are mutagenized (Fig. 3-2, p. 68).   
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     The B. quintana hut locus is similar to other bacterial hemin acquisition systems in 
that it is transcriptionally regulated in a hemin-responsive manner (Fig. 3-3, p. 69).  
Growth on low hemin results in a slight increase in hut locus mRNAs relative to the 
quantity obtained from growth on optimal hemin.  Although the difference in hemin 
concentrations between BA-2.5mM hemin and BA-0.15mM is much greater, the decrease 
in hut gene transcription is fairly modest.  Based on these data, it is tempting to speculate 
that changes in extracellular hemin are buffered in B. quintana, possibly by an accessory 
hemin-binding system, such as the Hbps.  Such a system could enhance the ability of B. 
quintana to withstand hemin fluctuations in the divergent environments of the body louse 
and human bloodstream.   
     Effects of overexpression of hemin/iron-responsive regulators (irr, rirA, and fur) 
indicate that hemin-responsive changes in hut locus transcription are primarily mediated 
by Irr.  Although Irr homologs have been reported to act as transcriptional activators of 
hemin/iron genes when hemin is limiting (25, 39), B. quintana Irr represses hut locus 
genes.  B. quintana Irr may also transcriptionally activate hut locus genes in the absence 
of hemin, but the absolute requirement for hemin by B. quintana prohibits investigating 
this possibility (31).  Our data suggest that irr overexpression results in repression of hut 
locus genes regardless of ambient hemin concentration, despite previous reports 
suggesting that B. japonicum Irr is degraded upon binding hemin (51).  Interestingly, the 
N-terminal heme response motif (amino acids 28-33) of B. japonicum Irr is not conserved 
in B. quintana Irr (51).  Likewise, only two of three histidine residues implicated in a 
second hemin-binding site (51) are present in B. quintana Irr and both B. quintana and E. 
coli Fur have two histidines in this position but are not degraded by hemin (data not 
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shown).  B. japonicum Irr represses protoporphyrin biosynthesis genes when heme is 
present, but the majority of these genes are not present in the B. quintana genome 
suggesting that B. quintana Irr plays a distinct role (6, 36).  Of specific interest, heme-
mediated degradation of Irr in B. japonicum requires ferrochelatase (36), but an 
orthologue is absent in B. quintana (2).   
     RT-PCR analyses show that the hut locus is expressed as three transcripts, originating 
from a divergent promoter region between hutA and tonB and a polycistronic mRNA 
transcribed from the region upstream of hemS (Fig. 3-5, p. 73).  Consistent with qRT-
PCR data from the irr overexpression strain, both promoters possess regions with 
considerable identity to a consensus sequence containing H-box (Fig 3-6, p. 74-5) (6).  
Unlike Hbps, the majority of which were activated by Irr, the consensus sequence 
encompassing H-box in the hut locus promoters either overlaps the -10 and -35 regions 
(hutA) or is located nearby (tonB and hemS).  A similar location for the ICE motif was 
reported in B. japonicum genes repressed by Irr (39, 40).  These data strongly suggest that 
Irr directly represses the hut locus.       
     In contrast to irr, rirA overexpression showed only minor changes in transcription of 
hut locus genes, regardless of hemin concentration (Fig. 3-4C, p. 72).  In the presence of 
excess hemin, fur overexpression resulted in decreased transcription of tonB (Fig. 3-4B, 
p. 71).  However, no obvious consensus Fur box sequence is evident in the promoter 
region of tonB (15).  The effect of fur overexpression on tonB may be indirect in B. 
quintana, but this seems unlikely as tonB is known to be repressed by Fur in other 
bacteria (32).  Most likely, Bartonella Fur recognizes a unique consensus sequence, as 
described for B. japonicum (15).           
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      To our knowledge, this is the first study to characterize a complete system of hemin 
acquisition in Bartonella.  Our data indicate that the hut locus is surprisingly similar to 
hemin uptake systems described in other Gram-negative bacterial pathogens and is 
primarily controlled by Irr.  However, given the importance of hemin to the survival and 
pathogenesis of Bartonella, B. quintana provides a unique model for studying its 
acquisition and utilization.  Interesting areas of future study include the interplay between 
the Hut proteins and potential accessory systems including proteins able to bind hemin 
(e.g., Hbp’s), proteins able to remove heme from hemoglobin, and proteins able to 
function as hemoglobin receptors.  Any of these systems would contribute to the success 
of Bartonella pathogenesis by buffering fluctuations in available heme and by allowing 
Bartonella to use the most abundant source of heme in the human host (16).   
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Table 3.1.  Bacterial strains and plasmids used in this study. 
 
Strains and plamids Description 
Source or 
reference 
Strains   
B. quintana   
     JK31 Low-passage human isolate J. Koehler 
     JK31+pBBR  JK31 with pBBR1MCS (6) 
     JK31+pBBR-FUR JK31 with pBBR-FUR (6) 
     JK31+pBBR-RIRA JK31 with pBBR-RIRA (6) 
     JK31+pBBR-IRR JK31 with pBBR-IRR (6) 
   
   
E. coli   
      JM109                            Host strain for cloning                                       Promega 
      TOP10F’                     Host strain for cloning                                       Invitrogen 
      EB53 hemA aroB rpoB (47) 
      IR754 EB53 but tonB::Kan (47) 
      EB53/pWSK29                                                    EB53 harboring pWSK29                                    This study 
      EB53/pNP1                                            EB53 harboring pNP1                                    This study 
      IR754/pWSK29                                   IR754 harboring pWSK29                                      This study 
     IR754/pNP1        IR754 harboring pNP1        This study 
                                                                                                                 
Plasmids   
        
 
  
     pCR2.1TOPO TA cloning vector Invitrogen 
     pNP2 pCR2.1TOPO containing B. quintana hutA This study 
     pWSK29 Low copy-number expression vector  (50) 
     pNP1 pWSK29 containing B. quintana hutA This study 
     pQE30 Expression vector for 6xHis-tagged fusion proteins Qiagen 
     pNP3 pQE30 containing B. quintana hutA  This study 
     pBBR1MCS Shuttle vector for Bartonella (21) 
     pBBR-FUR pBBR1MCS containing B. quintana fur (6) 
     pBBR-RIRA pBBR1MCS containing B. quintana rirA (6) 
     pBBR-IRR pBBR1MCS containing B. quintana irr (6) 
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Figure 3-1.  Arrangement and homology of B. quintana hemin uptake locus.   
A.  Genomic arrangement of the B. quintana hut locus and BLAST results indicating 
closest orthologues outside Bartonellaceae (percent amino acid identity: percent amino 
acid similarity), as well as predicted: function, isoelectric point (pI) and mass (kDa).   
B.  ClustalW alignment of C-terminal region of B. quintana HutA with 
hemin/hemoglobin receptors of Yersinia enterocolitica (HemR), Y. pestis (HmuR), and 
Haemophilus influenzae (HxuC).  Conserved FRAP and NPNL domains are boxed and 
shaded.  The tyrosine 505 substitution aligned with typically conserved histidines is 
indicated by bold-face type.  Fully conserved residues are indicated by a star, a colon 
shows strongly conserved residues, and a dot indicates weakly conserved residues.      
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Figure 3-2.  Complementation of E. coli hemA strains with B. quintana hutA.   
Growth curve of E. coli EB53 and IR754 containing pWSK29 (vector control) or pNP1 
inoculated into TY supplemented with: A) 10µg/ml or B) 50µg/ml hemin after a brief 
period of hemin/ALA starvation.  The asterisk (*) indicates a statistically significant 
difference in OD600 relative to controls.  
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Figure 3-3.  qRT-PCR analysis of  B. quintana hut locus transcription in response to 
hemin availability.  Average fold differences in hut locus transcript levels from JK31 
grown under hemin-limiting conditions (0.05mM) or excess hemin (2.5mM) relative to 
optimal levels (0.15mM).  Data represent the means of three independent determinations 
(per gene per condition) +/- standard deviation.    
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Figure 3-4.  qRT-PCR analyses of B. quintana hut locus in response to 
overexpression of various iron response regulators.  Average fold difference in hut 
locus transcription from: A) JK31+pBBR-RIRA, B) JK31+pBBR-FUR and C) 
JK31+pBBR-IRR relative to JK31+pBBR.  Strains were grown in parallel on BA-
0.05mM hemin, BA-0.15mM hemin, and BA-2.5mM hemin.  Data represent the means 
+/- standard deviation of three independent determinations. 
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Figure 3-5.  RT-PCR analysis verifies polycistronic nature of hut mRNA.   
PCR analysis of hmuV transcript components using gene-specific primers for each 
member of the hut locus except tonB.  (G), genomic DNA from JK31 used as template; 
(+), hmuV RT product used as template; (-), JK31 RNA without reverse transcription 
used as template.  DNA size standards are indicated in kbp on left and bp on right side of 
gel. 
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Figure 3-6.  TSS mapping and promoter regulatory regions of the hut locus showing 
the H-box.   
A.  TSS’s mapped by 5’RACE are indicated by a diamond (hutA) and arrowhead (tonB).  
Putative -10 and -35 promoter elements are shown with directionality, and the horizontal 
arrow and bold-face type indicate the hutA and tonB genes.  The consensus sequence that 
interacts with B. quintana Irr (6) is boxed.  Note the consensus is on the inverse 
complement (lower) strand. 
B.  TSS of hems is indicated in bold by the star.  Potential -10 and -35 sites are indicated 
and the region containing the consensus sequence that interacts with B. quintana Irr (6) is 
boxed.  The hemS gene is indicated by the horizontal arrow and bold-face type. 
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CHAPTER FOUR 
Bartonella quintana HemS is a Hemin Binding Protein with Potential Heme 
Oxygenase Activity 
 
A.  INTRODUCTION 
 
     An extraordinarily high hemin requirement for in vitro growth is a hallmark of 
Bartonella species, and meeting this requirement is undoubtedly pivotal to its ability to 
cause disease in the context of the human host.  Recent work with Bartonella quintana 
has focused on the mechanisms of hemin acquisition resulting in the characterization of 
the hemin utilization locus (hut) and the hemin binding protein family members (HbpA-
E).  The ability to obtain iron, either free or from the breakdown of heme, is largely 
undefined in Bartonella.  It has been established that iron and protoporphyrin IX are not 
sufficient for in vitro growth in the absence of hemin itself, but this may result from the 
lack of ferrochelatase rather than the inability to acquire iron (4, 152).  Analysis of the B. 
quintana genome indicates two potential systems for iron uptake, namely the yfe (A-D) 
locus for manganese, zinc, and possibly ferric iron acquisition and the ceuD/fat (B-D) 
locus for siderophore-mediated iron acquisition (4).  However, the B. quintana yfe locus 
lacks a homolog to yfeE, which was shown to be an essential component of the Yersinia 
system in complementation assays of an E. coli enterobactin mutant (15).  Furthermore, 
there are no obvious candidates for siderophore synthesis genes in the B. quintana 
genome (Battisti and Minnick, unpublished observations).  In addition to the ambiguity 
surrounding iron uptake, the mechanism of protection from heme-mediated cytotoxicity 
is unclear.  One potential solution that provides iron and neutralizes heme-mediated 
oxidative damage is the utilization of a heme oxygenase (HO). 
       Originally characterized in mammalian cells, membrane associated HOs act in 
conjunction with NADPH-cytochrome P450 reductase to catalyze the breakdown of 
heme into biliverdin, carbon monoxide (CO) and free iron (Fe
2+
).  Biliverdin is then 
converted by biliverdin reductase to bilirubin (94).  Heme breakdown can also occur via 
coupled oxidation which, like HO-mediated catabolism, generates meso-hydroxyheme 
and verdoheme intermediates.  However, the two reactions can be distinguished by 
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inhibitors and end products.  In particular, coupled oxidation does not occur in the 
presence of catalase whereas HO-mediated catabolism does. Also, coupled oxidation 
nonspecifically degrades heme generating a mix of biliverdin isomers, whereas HO-
mediated catabolism proceeds to the specific generation of α-biliverdin in almost all 
instances (10, 94).  Although the detoxification of free heme is thought to be the primary 
function of mammalian HOs, secondary functions include protection from cellular injury 
through generation of the antioxidants biliverdin and bilirubin and maintenance of 
homeostasis through CO signaling (19, 94) . 
      Unlike the situation described in eukaryotes, bacterial HOs are soluble, their in vivo 
reductase partners are largely undefined, the fate of biliverdin is unclear, and their 
primary function is presumably to release iron from heme.  Due in part to considerable 
homology with human HO-1, one class of bacterial HO has been characterized in the 
Gram-positive pathogen Corynebacterium diphtheriae (192).  Another example is the 
Gram-negative Neisserial HemO protein which also bears some resemblance to 
eukaryotic HOs.  Studies suggest that the Neisserial HemO degrades heme into ferric-
biliverdin IXα and CO rather than releasing free iron and biliverdin, but this may be the 
result of a weak interaction with a surrogate reductase partner (198).  In Pseudomonas 
aeruginosa, PigA also has homology to the HemO/HmuO class of heme oxygenases and 
has been shown to function as such (140).  Of note, this HO, like coupled oxidation, 
generates a mixture of biliverdin IX-β and biliverdin IX-δ rather than the biliverdin IX-α 
product characteristic of HO-catalyzed heme degradation.   It is also unable to efficiently 
interact with the NADPH-cytochrome P450 reductase (140).  The widespread use of 
heme by pathogenic bacteria implies that utilization of a HO to liberate iron from heme 
might also be widespread.  Interestingly, one report indicates that database searches of 
bacterial genomes have identified homologs to HmuO and HemO in only Deinococcus 
and Legionella, suggesting that either the strategy of iron release from heme via HO-
mediated degradation is rare or that many bacterial species encode a novel HO enzyme 
(140).       
     Not surprisingly, analysis of the B. quintana genome also indicates the absence of a 
mammalian HO homolog, but it does encode a potential hemin-degrading protein, HemS.  
The precise function of HemS homologs is somewhat controversial.  Initial experiments 
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suggested that the Shigella dysenteriae homolog, ShuS, formed an oligomeric ferritin-like 
structure that functions as a heme-storage protein (191).  This result was modified to 
suggest that ShuS complexed with heme exists as a dimer, while the oligomeric structure 
arises from heme-free ShuS bound to DNA (91).  This occurrence led Kaur and Wilks to 
hypothesize a Dps-like role in protection of DNA from oxidative stress, but ShuS-bound 
DNA was not fully protected from oxidative stress and shuS was not able to complement 
an E. coli dps mutant (91).  Examination of the P. aeruginosa homolog, PhuS, indicates 
that heme can be degraded by this protein in the absence of catalase but not in its 
presence.  The authors attributed degradation to the coupled oxidation mechanism and 
proposed that PhuS functions as a heme-trafficking protein that facilitates the transfer of 
heme to PigA (106).  The closely related Yersinia enterocolitica HemS was required for 
efficient utilization of heme as an iron source, but not as a porphyrin source, in 
complementation studies involving E. coli EB53 (165).  Y. enterocolitica HemS was also 
required to prevent cytotoxicity, presumably resulting from the accumulation of excess 
heme, in E. coli strains expressing the recombinant hemin receptor, HemR, from a high-
copy plasmid (166).  Based on these observations, heme oxygenase activity was proposed 
for HemS despite the absence of sequence similarity to known HOs or experimental 
evidence of this catabolic capability (166, 192).  Evidence of enzymatic activity was 
obtained for the ChuS homolog from E. coli O157:H7, which was shown to function as a 
HO by specific degradation of heme accompanied by generation of carbon monoxide in 
the presence of an electron source, in vitro.  The generation of free iron and biliverdin 
was assumed based on spectral data and culture pigmentation (169).  The suggestion that 
ChuS-mediated heme degradation occurs via coupled oxidation was addressed by the 
addition of catalase or superoxide dismutase to the reaction.  Neither of these agents 
inhibited the decomposition of heme, but mutagenesis of a highly conserved histidine 
residue completely abolished enzymatic activity (168).  These data provide strong 
evidence for the existence of a novel HO that has homologs in many bacterial species.   
     Due to the fact that heme is assumed to be the primary source of iron and porphyrin in 
the human host, especially in the intracellular erythrocyte environment, we hypothesized 
that HemS functions as a heme oxygenase.  However, it should be noted that heme-
trafficking/chaperone functions are not necessarily exclusive of heme oxygenase 
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functions.  These studies were undertaken to elucidate the function of HemS in an effort 
to better understand heme/iron acquisition in Bartonella.   
 
B.  MATERIALS AND METHODS 
 
     Bacterial strains, media, and culture conditions.  E. coli strains were routinely 
grown overnight at 37
o
C in Luria-Bertani (LB).  Gene expression was induced by the 
addition of 0.1 mM to 2.5 mM isopropyl-β-D-thiogalactopyranoside (IPTG) to mid-log 
phase cultures prior to an additional 4-6 h incubation.  Corynebacterium ulcerans strains 
CU712 hmuO∆ and CU712 hmuO∆/pCUhmuO (generously provided by Michael 
Schmitt) were routinely grown overnight at 37
o
C in heart infusion broth (HIB) containing 
0.2% Tween 80 (HIBTW) unless otherwise stated (104, 135).  Standard antibiotic 
concentrations were supplied as needed. Strains used in this study are listed in Table 4.1 
(p. 94).  
  
     Analysis of sequence and structural similarity.  The National Center for 
Biotechnology Information website (http://www.ncbi.nlm.nih.gov) and the RhizoDB 
website (http://xbase.bham.ac.uk/rhizodb/) were used for genome searches and sequence 
retrievals.  Multiple amino acid sequence alignments were performed with ClustalW 
version 2.0 and comparison with sequence databases were performed with BLAST (5, 
108).  Structural predictions were made with the Protein Homology/Analogy Recognition 
Engine (Phyre) version 0.2 (http://www.sbg.bio.ic.ac.uk/~phyre/) (92).       
 
     DNA preparations and plasmid construction.  A DNeasy blood and tissue kit 
(Qiagen, Valencia, CA) was used for the preparation of genomic DNA.  Small-scale 
plasmid purification was performed with a QIAprep miniprep kit (Qiagen) and large-
scale preparations were obtained with a Wizard Plus midiprep kit (Promega, Madison, 
WI).  Standard protocols were employed for PCR amplification, restriction digestion, 
ligation, and cloning (8).  Primers used in this study are listed in Table 4.2 (p. 95).   
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     HemS expression and purification.  Overnight cultures of JM109/pQE30HemS were 
expanded and grown to mid-log phase then induced with 2.5 mM IPTG for 5-7 h.  Cells 
were centrifuged at 10,000 x g for 10 min at 4
o
C, and resulting pellets were placed in -
20
o
C until needed.  Because attempts to purify soluble His6-tagged HemS resulted in very 
low yields, purification was performed under denaturing conditions per QIAexpressionist 
(Qiagen) protocol with minor modifications.  Briefly, denatured HemS was purified with 
Ni
++
NTA (nickel nitrilotriacetate) resin per protocol except the column was washed twice 
with 4 mls Buffer C each time.  Elution was monitored by sodium dodecyl sulfate-
polyacrylamide gel electrophoresis (SDS-PAGE) using 12.5% (wt/vol) acrylamide gels, 
which indicated partial purification of HemS in the third and fourth fractions of Buffer E.  
These fractions were combined and refolded against dialysis buffer (100 mM NaH2PO4, 
600 mM NaCl, 20% glycerol, pH 8.0) in a 3500 MWCO (molecular weight cut-off) 
Slide-a-Lyzer cassette (Pierce, Rockford, IL) (135).  Re-folded HemS was concentrated 
with PEG [poly(ethylene glycol)] 20,000 (Alfa Aesar, Ward Hill, MA).  Pooled samples 
were further concentrated by ultrafiltration using an amicon stir cell with a 30,000 
MWCO membrane.  Samples were stored at -20
o
C until needed.  
 
     Spectral analysis of hemin binding.  Hemin binding to HemS was assessed 
spectrophotometrically with an HP8453 A diode array UV/VIS spectrophotometer.  
Briefly, 81.25 nM of hemin was added incrementally to the sample cuvette containing 3 
ml of HemS (27µM/L) or the reference cuvette (containing buffer only) in 6.25 nM 
aliquots.  Hemin was incubated with HemS for 5 min at room temperature after each 
addition, and the absorbance spectrum from 300 nanometers (nm) to 800 nm was 
recorded for each.  Data obtained for the reference cuvette were subtracted from data 
obtained from the sample cuvette to generate difference spectra.  Data from two 
independent experiments were used for nonlinear regression analysis with Prism software 
from GraphPad (http://graphpad.com).   
  
 
     Hemin blots.  A bicinchoninic acid protein kit (Sigma Chemicals, St. Louis, MO) was 
used for protein quantification.  SDS-PAGE followed the general methods of Laemmli 
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(105).  Gels were stained with Coomassie brilliant blue for visualization or transferred to 
nitrocellulose according to the methods of Towbin (8, 173).  Hemin blots were basically 
performed as described (31).  In brief, blots were blocked for 1 h with Tris-buffered 
saline (TBS-Tween 20) (10 mM Tris, 150 mM NaCl, 0.1% Tween 20) containing 2% 
nonfat dry milk then washed twice with TBS.  Blots were then incubated for 1.5 h in 
TBS-Tween 20 containing 10 µg/ml hemin, washed three times (30 min each) in TBS-
Tween 20, developed using enhanced chemiluminescence (ECL) reagents (Pierce, 
Rockford IL) and visualized with autoradiographic film (Eastman Kodak Co., Rochester, 
NY).       
 
     Electroporation of Corynebacterium.  Corynebacterium ulcerans strains were 
transformed essentially as described (74).  Ten ml of overnight CU712hmuO∆ culture 
was used to inoculate 100 ml of HIBTW supplemented with 20 ml of 20% glycerol.  
Cultures were incubated 1 h at 37
o
C then diluted to OD600 ~0.4.  Cells were centrifuged at 
10,000 x g for 10 min at 4
o
C and the resulting pellet was washed with 200 ml cold 15% 
glycerol.  Cells were centrifuged again and resuspended in a final volume of 400 µl cold 
15% glycerol.  A 40 µl volume of this suspension was mixed with plasmid DNA (1.4 µg 
to 34.3 µg) in a 2mm gap electroporation cuvette (BTX, Holliston, MA).  Cells were 
electroporated with a GenePulser (Bio-Rad, Hercules, CA) set at 2.5kV, 25µF and 200Ω.  
HIBTW (900 µl per cuvette) was added immediately after the pulse and cells were 
incubated at 30
o
C for 1.5 h prior to plating.   
 
     Complementation of C. ulcerans hmuO∆.  Complementation of C.  ulcerans was 
performed as described previously (135).  In brief, the C. ulcerans CU712hmuO∆ strain 
was transformed with the E. coli-Corynebacterium shuttle vector pKN2.6Z (kindly 
provided by M. Schmitt) containing B. quintana hemS (46).  CU712hmuO∆ containing 
vector only served as a negative control and CU712hmuO∆/pCUhmuO served as a 
positive control.  Strains were grown overnight at 37
o
C in HIBTW then diluted 1:1000.  
25 µl aliquots of these dilutions were used to inoculate HIBTW supplemented with 200 
µg/ml of the iron chelator ethylenediamine-N,N’-bis(2-hydroxyphenyl acetic acid) 
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(EDDHA), alone, or in conjunction with 1 mM FeSO4 or 7 µM hemin.  Plates were 
scored for visible growth following overnight incubation at 37
o
C. 
 
     DNA Sequencing.  An automated DNA sequencer (AB3130x1 genetic analyzer) and 
a BigDye Terminator cycle sequencing ready reaction kit 3.1 (ABI, Foster City, CA) 
were used to obtain sequence data.  Data were analyzed with ChromasPro 1.13 software 
(http://www.technelysium.com.au/ChromasPro.html).       
 
C.  RESULTS 
 
        Sequence conservation and predicted structural similarities between B. 
quintana HemS and E. coli ChuS.  Initial examination of B. quintana HemS focused on 
identifying similarities to other HemS homologs, specifically concentrating on the E. coli 
ChuS protein.  BLAST analyses of ChuS from 0157:H7 against the B. quintana genome 
indicate 33% amino acid identity and 50% similarity across 327 of 347 HemS residues.  
The crystal structure of ChuS has been solved and indicates a novel HO structure 
consisting of 9 anti-parallel β-strands contributing to the formation of two large β sheets 
(168, 169).  Several amino acids required for stabilization of the heme-binding interaction 
or enzymatic activity were identified.  Clustal alignment of HemS with ChuS indicates 
complete conservation of all amino acid residues involved in stabilization of heme 
binding except for the replacement of one tyrosine (Tyr 315) with a phenylalanine in B. 
quintana HemS (See Fig. 4-1A, p. 96).  Most importantly, the key histidine residue (His 
193) for coordinating heme and required for oxygenase activity is conserved, as is the 
second coordinating residue, Arg 100 (168).  The predicted three-dimensional structure 
of B. quintana HemS aligned with the E. coli ChuS structure determined by 
crystallography.  This alignment shows positional conservation of the heme coordinating 
residues within the heme-binding cleft identified by crystallization of the ChuS-heme 
complex (Figure 4-1B, p. 97).  Although HemS and ChuS share relatively low amino acid 
identity, these data suggest that the majority of critical residues for heme binding and 
oxygenation are conserved and the two proteins share a high degree of structural 
homology.     
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     His6-tagged HemS expression and hemin binding in E. coli.  The successful 
construction of a pQE30 plasmid encoding a his6-HemS fusion, termed pQE30HemS, 
was initially confirmed by DNA sequencing.  Sequence analyses indicate the presence of 
a point mutation resulting in the substitution of an arginine residue at position 10 (Arg 
10) with a leucine (data not shown).  Despite the presence of this mutation, all 
experiments were performed using this clone.  This decision was justified in part by 
difficulties in obtaining the clone and in part by the fact that Arg10 is not conserved in 
ChuS (See Fig. 4-1A, p. 96).  Protein synthesis was confirmed by SDS-PAGE and those 
analyses indicate production of a unique inducible protein of ~40 KDa (See Fig. 4-2A, p. 
98).  This is in accordance with the predicted molecular mass of 39.4 KDa for native 
HemS.  Expression of recombinant HOs in E. coli can confer a blue-green pigment to 
cells that others have attributed to the accumulation of biliverdin (169, 198).  However, 
this phenomenon was not observed during expression of the B. quintana His6-HemS 
protein regardless of expression level.  Examination of the hemin binding ability of 
HemS by hemin blotting indicates that His6-HemS binds hemin at levels well above 
background (See Fig. 4-2B, p. 98).  Based on these data, the His6-HemS protein is 
expressed and inducible in E. coli.  Although HemS synthesis does not generate visible 
indications of biliverdin accumulation, it is able to bind hemin in a strong and specific 
manner independently of Arg 10.         
 
     Spectral analyses of hemin binding.  For further exploration of the hemin binding 
capacity of His6-HemS, the protein was purified and renatured for spectrophotometric 
analysis of heme binding.  Difference spectra were obtained by subtracting the 
absorbance of hemin in buffer alone from the spectra obtained from hemin added to His6-
HemS in buffer.  These difference spectra, similar to those obtained from other HOs, 
show a Soret maximum at 411 nm which is indicative of hemin binding (See Fig. 4-3A, 
p. 99).  Additionally, the absorbance of bound hemin in 350 nm range is lower than that 
obtained from free hemin resulting in a trough (B. Lei, personal communication).  
Although β and α bands (at ~545 and 580nm, respectively) have been reported for other 
bacterial HOs, they are not evident in the difference spectra obtained for the hemin-His6-
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HemS complex.   Presumably, the absence of these bands is due to the relatively low 
concentration of His6-HemS compared to the concentrations of protein used in other 
studies (140, 169).  Nonlinear regression analyses of the change in absorbance at 411 nm 
(∆OD411) versus hemin concentration best fit a one-binding site model (See Fig. 4-3B, p. 
100).  The estimated Kd is 5.9 + 1.7 µM and the increase in absorbance appears to even 
out at ~25 µM suggesting a 1:1 ratio of hemin to protein.  The estimated Kd reported here 
is higher (lower affinity) than that reported for several HOs, but fairly close to the 
estimated Kd of the IsdG hemin-degrading enzymes of Staphylococcus aureus and 
Bacillus anthracis (159, 160).   
 
     B. quintana HemS does not complement a C. ulcerans CU712hmuO∆ strain.  
Attempts to reconstitute HemS heme oxygenase activity in vitro have been unsuccessful 
to date.  An alternative strategy for examining the function of HemS is the 
complementation of a HO mutant strain.  Unfortunately, few such strains exist.  Despite 
the distant relationship between B. quintana and C. ulcerans and the fact that HmuO 
represents a different class of bacterial HO, the existence of CU712hmuO∆ provided a 
potential strain for complementation assays in an attempt to define the function of HemS 
in vivo (104).  In order to explore the hypothesis that hemS could functionally repair the 
hmuO defect, the B. quintana hemS gene was cloned into the Corynebacterium-E. coli 
shuttle vector pKN2.6Z.  Of note, attempts to identify or induce HemS from pKN2.6Z in 
E. coli were unsuccessful but the presence of the insert was confirmed by PCR and DNA 
sequencing (data not shown).  CU712hmuO∆ strains containing pKNHemS or pKN2.6Z 
alone were tested for the ability to utilize hemin as the only source of iron.  Control 
strains included the mutant, CU712hmuO∆, and the mutant strain complemented with its 
own hmuO gene, CU712hmuO∆/pCUhmuO.  As expected, none of the strains grew on 
iron-chelated media and all of the strains grew on media supplemented with FeSO4.  Like 
CU712hmuO∆, CU721hmuO∆/pKNHemS was unable to grow on plates supplemented 
with hemin.  In contrast, the strain complemented with C. ulcerans hmuO grew well with 
hemin as a sole iron source (See Fig. 4-4, p. 101).  These results show that B. quintana 
hemS is not sufficient to restore growth of the C. ulcerans hmuO∆ strain on iron-depleted 
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medium supplemented with hemin.  Not surprisingly, in light of the inability to induce 
HemS expression in E. coli, supplementation of media with IPTG did not alter these 
results.      
 
D.  DISCUSSION 
 
     Although one hemin acquisition system, the Hut locus, has been characterized in B. 
quintana, neither the fate of hemin in the cytoplasm nor the mechanisms used for iron 
acquisition are currently understood.  We hypothesized that one member of the Hut locus, 
HemS, was able to bind and degrade hemin.  The data presented herein clearly indicate 
that HemS has amino acid and structural similarities to the E. coli HO, ChuS, and that 
HemS is able to bind hemin.  Experiments performed to date have not provided in vitro 
or in vivo evidence of heme oxygenase activity.  Nevertheless, these results may be 
ascribed to the generation of a spurious mutation while cloning hemS and the 
complementation system chosen rather than an authentic absence of enzymatic activity. 
     With respect to the mutation of Arg10 in HemS, the replacement of the positively 
charged, basic side chain of arginine with the nonpolar side chain of leucine may have 
altered proper folding of HemS.  The inability to purify large quantities of soluble His6-
HemS may also be attributable to this mutation, as several studies report the generation of 
soluble recombinant His-tagged heme oxygenases (140, 169, 198).  Alternatively, the 
inability to reconstitute in vitro HO activity may simply have resulted from relatively low 
concentrations of His6-HemS compounded by potentially incomplete renaturation.  The 
use of a C-terminal histidine tag or a glutathione-S-transferase (GST) tag will be 
considered for future cloning and purification attempts.  Until these potential issues have 
been resolved, the ability of HemS to function as a heme oxygenase in vitro cannot be 
ascertained with any confidence.   
     With respect to the C. ulcerans complementation system, it was initially chosen due to 
the absence of an alternative HO mutant strain.  However, the fact that HmuO represents 
a different class of HO presents at least one potential pitfall that could result in the 
inability of one class to substitute for the other.  Namely, the two classes of bacterial HOs 
may utilize different reductase partners in vivo.  In support of this explanation, the P. 
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aeruginosa HO, PigA, which also belongs to the HmuO/HemO class of bacterial HOs 
was unable to efficiently use the NADPH-cytochrome P450 reductase system for in vitro 
heme degradation (140).  As with the in vitro experiments, there are too many potential 
problems with the complementation assays for these negative data to definitively rule out 
the hypothesis that HemS possesses heme oxygenase activity. 
       An E. coli chuS mutant in an 0157:H7 background was recently generated, and may 
provide an alternative complementation system (176).  The phenotype of this strain is 
currently unknown, but it may be unable to use hemin as a sole iron source if grown on 
iron-depleted media.  In an effort to overcome the difficulties associated with attempting 
to complement the CU712hmuO∆ strain, collaborations are currently planned to examine 
the phenotype of the chuS mutant and, if an appropriate phenotype exists, attempt to 
complement it with B. quintana hemS (C. Martin, personal communication).  Provided 
the mutant has a testable phenotype, the utilization of an E. coli chuS strain for 
complementation assays has a much higher chance of succeeding because of the 
homology between ChuS and HemS.   
     A final point of interest, albeit speculative, regarding potential heme oxygenase 
activity in B. quintana is the existence of a hypothetical gene (BQ09510) that shares 22% 
identity and 44% similarity with 165 of 296 amino acids of human biliverdin reductase 
A.  Moreover, BQ09510 also shares 23% identity and 41% similarity across 254 amino 
acids to the cyanobacterial biliverdin reductase, BvdR (155).  In addition to implying HO 
activity in B. quintana, a biliverdin reductase would also supply a cycling mechanism for 
the powerful antioxidant bilirubin.  Evidence from mammalian cells suggests that minute 
amounts of bilirubin can protect lipids from massive hydrogen peroxide challenge.  The 
ability of low concentrations of bilirubin to be highly cytoprotective has been attributed 
to the fact that oxidization of bilirubin generates biliverdin which is in turn reduced back 
to bilirubin by biliverdin reductase (157).  Thus, examination of the function of BQ09510 
would be an interesting avenue for future studies in terms of elucidating both heme 
metabolism and the closely related oxidative stress response.  
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Table 4.1.  Bacterial strains and plasmids used in this study. 
 
Strain or plasmid Description Source or reference
Strain
     B. quintana
          JK31 low passage human isolate J. Koehler
     E. coli
          JM109 Host strain for cloning Promega
           TOP10F' Host strain for cloning Invitrogen
     C. ulcerans
          CU712humO ∆ CU712 with a 305bp internal deletion of hmuO M. Schmitt
          CU712hmuO ∆/pCUhmuO CU712hmuO ∆ harboring pCUhmoO M. Schmitt
          CU712hmu O∆/pKN2.6Z CU712hmuO ∆ harboring pKN2.6Z This study
          CU712hmuO ∆/pKNHemS CU712hmuO ∆ harboring pKNHemS This study
Plasmid
     pKN2.6Z Corynebacterium-E. coli  shuttle vector M. Schmitt
     pKNHemS pKN2.6Z with B. quintana hemS This study
     pQE30 Expression vector Qiagen
     pQE30HemS pQE30 with B. quintana hemS This study  
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Table 4.2 Primers used in this study. 
 
Primers
SacIhemSfor TGAGCTCGCTGAAACGATTATTCGTTTGC
HindIIIhemSrev GGGAAGCTTTCGATATTTTTCAGCTTTGG
SalIhemSfor CATGTCGACCTATGGCACATAAAGCTGAAACG
EcoRVhemSrev GGATATCCGATATTTTTCAGCTTTGGGGC
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A) 
 
 
Figure 4-1.  Similarity of B. quintana HemS to the E. coli heme oxygenase ChuS.  A) 
Clustal alignment of B. quintana HemS with ChuS from E. coli 0157:H7 strain EDL933.  
Conserved residues involved in heme binding are boxed and shaded and the histidine 
(His193 of E. coli) required for enzymatic activity is indicated by the large star.  A dot 
indicates weakly conserved residues, a colon indicates strongly conserved residues, and a 
star indicates fully conserved residues.  B)  Three-dimensional model of HemS shows 
structural similarity to E. coli ChuS.  The predicted positions of conserved residues 
required for coordinating and degrading heme are highlighted in yellow.  
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 A)                                                                      B) 
 
Figure 4-2.  Recombinant his6-tagged HemS is able to bind hemin.  Lanes: 1, 
JM109/pQE30 (uninduced); 2, JM109/pQE30 (induced); 3, JM109/pQE30HemS 
(uninduced); 4, JM109/pQE30HemS (induced).  A)  Coomassie blue stained SDS-PAGE 
gel.  B)  Corresponding hemin blot showing hemin bound to HemS.  Molecular mass 
standards are indicated on the left in kilodaltons. 
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A) 
 
 
Figure 4-3.  Spectral analysis of hemin binding.  A)  Difference spectra of His6-HemS 
with increasing amounts of hemin added shows a Soret maximum at 411 nm and a trough 
peak at ~350 nm.  The increased absorption at 411 nm following addition of increasing 
amounts of hemin is indicated by the arrow.  B)  Nonlinear regression of the change in 
absorbance at 411 nm versus the concentration of hemin.  Data shown are the mean and 
standard deviation of two independent experiments. 
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Supplement
Strain 200µg/ml EDDHA 1mM FeSO4 7µM Hemin
CU712hmuO ∆ No growth +++ No growth
CU712hmuO ∆/pCUhmuO No growth +++ +++
CU712hmuO ∆/pKN2.6Z No growth +++ No growth 
CU712hmuO ∆/pKNHemS No growth +++ No growth
 
Figure 4-4.  Complementation of C. ulcerans hmuO∆ strains.  Strains were plated to 
HIB containing 200 µg/ml EDDHA alone, or supplemented with 1 mM FeSO4, or 7 µM 
hemin and visually scored for growth after overnight incubation.  “+++” indicates a lawn.  
Results are representative of three separate experiments. 
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CHAPTER FIVE 
 
DISCUSSION 
 
     Neither free iron nor free hemin is abundant in the human host and the scarcity of 
these nutrients is exacerbated by the innate iron/hemin sequestration response to infection 
(186).  Pathogens must overcome these limitations if they are to be successful.  
Elucidation of the mechanisms and control of bacterial hemin/iron acquisition will 
enhance understanding of this aspect of bacterial adaptation to its host environment, may 
indicate novel regulation of virulence determinants in response to environmental cues, 
and has the potential to identify novel targets for the generation of new antimicrobial 
agents by rational drug design.  The need for novel antibiotics is predicted to become 
increasingly urgent due to the continued emergence of multidrug resistance in several 
pathogens (128)   Previous studies indicated that Bartonella required an extraordinary 
amount of hemin for in vitro growth, possessed a novel family of hemin binding proteins 
(HbpA-E), and was able to rapidly shift between the extreme differences in free hemin 
availability found in the human host and the body louse (123, 152).  These reports laid 
the foundation for the current studies, which were undertaken with the aim of 
characterizing the hemin/iron acquisition and regulation mechanisms employed by B. 
quintana. 
     The initial exploration of potential hemin receptors focused on the Hbps.  An HbpA 
homolog, Pap31, from B. henselae reportedly functioned as a hemin receptor when 
recombinantly expressed in E. coli and the hbp genes were shown to be transcriptionally 
responsive to the alteration of external cues associated with colonization of either the 
body louse or the human blood stream, including oxygen and hemin concentration (13, 
199).  Contrary to the prevailing hypothesis of the time, B. quintana HbpA was unable to 
function as a hemin receptor in E. coli.  The exact function of the Hbps is still unclear, 
but their importance in mediating human infection is underscored by the fact that one of 
them (HbpE) is a predominant outer membrane protein recognized by sera obtained from 
infected individuals (23).  Furthermore, their specific interaction with both hemin and 
hemoglobin suggests this binding has a biologically relevant purpose.  The potential 
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relevance of the hemin/hemoglobin interaction is accentuated by the fact that the closely 
related Neisserial opa genes are upregulated when cells are grown on media containing 
hemoglobin as the only iron source relative to that found when transferrin is the sole iron 
source (87).   
     Although purely speculative, the possibility of heme bound to the Hbps acting as a CO 
sensor is intriguing.  Carbon monoxide is a potent second messenger molecule in the 
human body that increases expression of the anti-inflammatory cytokine, IL-10, in 
macrophages (19).  Interestingly, cytokine profiles obtained from homeless people with 
chronic B. quintana bacteremia show a specific increase in IL-10 secretion that is 
believed to contribute to bacterial persistence (29).  Thus while CO may signal an anti-
inflammatory state in the human host it seems plausible that it may also serve as a signal 
to the bacterium indicating an environment conducive to the establishment of bacteremia.  
Alternatively, it has been hypothesized that the Hbps may induce a microaerobic 
environment by binding O2, or serve as a surface hemin storage site. Regardless of their 
actual function(s), the Hbp-hemin interaction represents a fascinating aspect of 
Bartonella biology that clearly warrants future study.  
     The transcriptional response of the hbps served as the impetus for study of hemin 
and/or iron-responsive gene regulation.  The identification of a Fur homolog in B. 
quintana led to the investigation of this protein as the potential mediator of hemin-
responsive transcriptional control of the hbpgenes (131).  B. quintana fur is in a unique 
arrangement relative to the fur gene of other bacterial species in that it is 17 bp 
downstream from the secA gene encoding the ATPase component of the general secretory 
pathway (182).  Although B. quintana fur encodes a functional repressor that recognizes 
the E. coli “Fur box” consensus sequence when recombinantly expressed under control of 
an exogenous promoter, no support for endogenous promoter activity or in vivo 
expression was obtained in these studies.  These data add to a growing body of evidence 
that challenges the γ-proteobacterial model of Fur as the primary iron-responsive gene 
regulator by showing that its role is lessened or even absent in α-proteobacteria (148).  It 
is within the realm of possibility that B. quintana fur is expressed under some 
undetermined condition, perhaps requiring a novel Bartonella-specific sigma factor.  In 
support of this possibility, forced overexpression of Fur in B. quintana resulted in 
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decreased transcription of hbpC and tonB relative to control strains (14).  As the gut of 
the body louse is expected to have the highest concentration of free hemin, it would be 
interesting to examine fur expression, perhaps using the fur promoter-gfp fusion 
constructs described by Parks et al, in B. quintana during a louse infection (131). 
     The inability to identify a native promoter for fur led to investigation of the Fur 
superfamily transcriptional regulator, Irr.  Although attempts to generate an irr knockout 
were not successful, Irr overexpression in B. quintana resulted in a “bloodstream-like” 
profile of hbp transcription.  Specifically, hbpA, D, and E transcript levels were increased 
relative to that observed in controls.  Additionally, purified recombinant Irr was shown to 
bind to a conserved motif found in the promoter region of the hbps, termed the H-box 
(14).  These data, combined with the absence of a role for Fur, suggest that Irr has 
assumed the role of primary hemin-responsive transcriptional regulator in Bartonella.  It 
would be interesting to examine the effects of Irr overexpression on the B. quintana 
genome to see if it also regulates potential virulence determinants.  
     Upon successfully identifying a major transcriptional regulator of the hbp genes, 
efforts were refocused on identification of the principal hemin uptake system of B. 
quintana.  By genomic analyses, the hut locus was chosen as the most likely candidate.  
The ability of HutA to function as a hemin receptor was confirmed by complementation 
assays using an E. coli strain unable to either synthesize or import porphyrin.  
Complementation assays were also used to establish the TonB-dependence of HutA-
mediated hemin transport.  Both the structure of HutA and the genetic organization of the 
hut locus are remarkably similar to hemin acquisition systems described in other Gram-
negative bacteria (165).  The extensive conservation found in bacterial hemin uptake 
systems makes them attractive candidates for the generation of new antibiotics.  At least 
one study has examined the possibility of exploiting bacterial hemin/hemoglobin uptake 
systems for the delivery of non-iron metalloporphyrins.  Gallium protoporphyrin IX was 
toxic to a range of bacterial pathogens, but relatively well tolerated by human fibroblasts 
and a mouse model (167).  This report provides preliminary evidence confirming the 
viability of exploiting hemin acquisition systems as an antimicrobial approach.    
     Based on its function as a hemin transport system, the hut locus was expected to be 
transcriptionally responsive to alterations in available hemin and this was confirmed by 
 108 
qRT-PCR.  Surprisingly, the relative difference in transcription levels was modest despite 
the fact that samples were obtained from bacteria grown on media supplemented with 
enormously different hemin concentrations.  These relatively small changes in hut locus 
transcription could hypothetically result from the existence of a hemin-storage reservoir 
or another buffering system.     
     B. quintana strains overexpressing Irr, Fur, and RirA, were used to investigate the 
transcriptional regulation of the hut locus.  Irr was identified as the primary mediator of 
transcriptional changes in the hut locus, even though Fur overexpression did result in 
decreased transcription of tonB when strains were grown in the presence of excess hemin.  
Unlike the hbp genes, some of which were induced by overexpression of Irr, the hut locus 
genes were repressed by Irr overexpression at all hemin concentrations tested.  These 
observations suggest that Irr is able to function as both an inducer and a repressor in B. 
quintana.  A similar situation has been reported in Bradyrhizobium japonicum, where the 
effect of Irr is a function of the location of the binding motif, termed an iron control 
element (ICE), relative to the start of the gene (149).  In accordance with these 
observations, consensus sequences similar to the H-box were identified in the hutA/tonB 
promoter region and in the hemS promoter region.  These sites overlap the predicted -10/-
35 promoter site of hutA and the predicted -35 promoter site of hemS.  In contrast, the H-
box identified in the promoter region of the hbp family members is at least 50 bp 
upstream of the start of the gene (14).  Thus, these data appear to fit the B. japonicum 
model where Irr functions as a repressor when bound near the transcriptional start site of 
a gene and an inducer when bound farther upstream.  As the consensus sequence 
encompassing the H-box is fairly large, an interesting area of future research would be to 
refine the motif to essential nucleotides by DNase footprinting and/or site-directed 
mutagenesis using a reporter gene fused to a promoter that contains the H-box.  
       While the majority of the Hut locus proteins have obvious roles, HemS is the subject 
of some controversy.  Numerous functions have been attributed to HemS homologs in 
other bacterial species including DNA binding, heme trafficking and heme sequestration 
(90, 91, 191).  The most interesting function for these proteins is a heme oxygenase 
activity attributed to the E. coli homolog, ChuS (169).  The possibility that B. quintana 
HemS functions as heme oxygenase is interesting for several reasons.  First, no heme 
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oxygenase with similarity to human HO-1, and therefore the major class of bacterial HO, 
is evident in the B. quintana genome.  Second, although systems with homology to ferric 
iron uptake (yfeA-D) and siderophore transport (fatB-D) are present in the genome, iron 
supplied with protoporphyrin IX is not adequate to support in vitro growth of Bartonella 
(152), nor are genes encoding a siderophore biosynthesis system readily apparent (Battisti 
and Minnick, unpublished data).  Third, even if Bartonella is able to acquire free iron, its 
availability in human erythrocytes is expected to be negligible.  Fourth, B. quintana has a 
marked absence of genes encoding iron-storage molecules (13).  Collectively these 
observations suggest an undefined mechanism in the acquisition of iron by B. quintana.  
Clearly, the presence of a HO would provide an iron source as long as heme was 
available.  Finally, ChuS, and by default HemS, has no structural similarity to any known 
HO but has homologs in a number of bacterial pathogens.  Given the scarcity of iron in 
the human host, inhibition of a unique HO presents an ideal target for therapeutic 
intervention.  
      Experiments to date have shown that HemS binds hemin with a 1:1 stoichiometry.  
The absence of enzymatic activity in in vivo experiments may result from the strain used 
for complementation analyses and in in vitro experiments may result from either the 
mutation in the His6-HemS construct or the relatively low concentration of protein used 
in the experiments.  Alternatively, Suits et al. reported that fresh ChuS was required to 
prevent aggregation (168).  However, generating sufficient amounts of HemS for in vitro 
examination of enzymatic activity without stockpiling several preparations would be 
problematic with the current construct.  An alternative and possibly more sensitive in 
vitro approach consists of measuring the release of 
55
Fe from [
55
Fe] protoporphyrin IXα 
(136).  However, this method may be a last resort due to the expense associated with 
obtaining radiolabeled hemin.  The identification of a chuS mutant in E. coli 0157:H7 is a 
promising avenue for examining the ability of HemS to function as a HO in vivo and the 
generation of a suitable construct for initiation of these studies is currently underway. 
     In summary, the studies described herein were undertaken with the aim of identifying 
the mechanism and regulation of hemin acquisition in B. quintana.  Data obtained from 
these studies have paved the way for further characterization of the Hbp family of 
proteins, which do not appear to function as hemin receptors but may serve an accessory 
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role in hemin acquisition. These studies have also contributed to the generation of a new 
model of iron and hemin-responsive transcriptional regulation whereby the 
transcriptional control provided by the Fur protein in γ-proteobacteria is provided by the 
related Irr protein in α-proteobacteria.  The primary hemin acquisition system of B. 
quintana was identified and shown to be under transcriptional control of Irr.  Initial 
examination of the function of HemS has been undertaken and several difficulties that 
need to be addressed in order to further investigate the function of this enzyme have been 
identified.  Numerous questions regarding hemin acquisition and utilization in Bartonella 
remain.  Arguably, the most interesting of these include the function of the Hbps and the 
fate of hemin upon delivery to the cytosol.  The answers to these questions, combined 
with the results presented here, will enhance understanding of the ability of these unique 
pathogens to cause disease in the human host.           
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